To see the other types of publications on this topic, follow the link: DNA Copy Number Variations.

Dissertations / Theses on the topic 'DNA Copy Number Variations'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 dissertations / theses for your research on the topic 'DNA Copy Number Variations.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse dissertations / theses on a wide variety of disciplines and organise your bibliography correctly.

1

Adur, Ashwin. "DNA copy number variation in autism." Connect to resource, 2009. http://hdl.handle.net/1811/37275.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Cervera, Carles Laura. "Assessing the role of copy number variations, mitochondrial DNA and microRNAs in neurodegenerative disorders." Doctoral thesis, Universitat Autònoma de Barcelona, 2019. http://hdl.handle.net/10803/668060.

Full text
Abstract:
Les malalties neurodegeneratives són patologies complexes i progressives que afecten milions de persones a tot el món. Entre d’altres, la malaltia d’Alzheimer (MA), la malaltia de Parkinson (MP) i la demència frontotemporal (DFT) són les tres condicions més prevalents. Tot i l’extensiva recerca duta a terme, els esdeveniments moleculars que desencadenen aquestes patologies són encara desconeguts. L’objectiu d’aquesta tesi és entendre el rol de determinats factors genètics i epigenètics en les malalties neurodegeneratives, a través de l’estudi de les reestructuracions genètiques, i la quantificació d’ADN mitocondrial circulant i espècies d’ARN no codificants. Primerament, s’ha analitzat el patró de variació estructural del cromosoma 17q21.31, una de les regions més complexes i dinàmiques del genoma humà, i s’ha avaluat la seva contribució en la ben establerta associació entre l’haplotip H1 del gen MAPT i la MP, la paràlisi supranuclear progressiva (PSP), la degeneració corticobasal (DCB) i la demència amb cossos de Lewy (DCLewy). Els resultats obtinguts suggereixen que els polimorfismes de número de còpies dintre d’aquesta regió no són responsables de l’efecte H1. Tot i això, hem trobat una sobre-representació dels portadors H1 en el grup de pacients amb DCLewy, expandint d’aquesta manera la rellevància biològica de l’haplotip en les malalties neurodegeneratives. També s’han examinat els nivells d’ADN mitocondrial circulant en líquid cefaloraquidi (LCR) i la seva utilitat com a indicador de la disfunció mitocondrial en el contínuum de la MA. Malgrat que la seva quantificació és fiable, la gran variabilitat interindividual entre els grups d’estudi limita la seva precisió i utilitat com a biomarcador diagnòstic. Finalment, s’ha investigat el perfil d’expressió de microARNs, una classe de ARNs no codificants involucrats en la modulació post-transcripcional de l’expressió gènica, continguts en vesícules extracel·lulars (VEs) de LCR en DFT i altres síndromes relacionats. Es poden detectar nombrosos microARNs en VEs de LCR. També s’han identificat quatre microARNs amb un patró d’expressió específic en pacients diagnosticats amb síndromes DFT 4R-tau.
Neurodegenerative diseases are complex and progressive disorders that affect millions of people worldwide. Among them, Alzheimer’s disease (AD), Parkinson’s disease (PD) and frontotemporal dementia (FTD) are three of the most prevalent. In spite of extensive research, the molecular events triggering these pathologies remain elusive. This thesis aims at understanding the role of certain genetic and epigenetic factors in neurodegenerative diseases through the study of structural genetic rearrangements, and the measurement of circulating mitochondrial DNA and non-coding RNA species. We first analyzed the structural variation pattern of the chromosome 17q21.31, one of the most complex and dynamic regions of the human genome, and evaluated its contribution to the well-established MAPT H1 haplotype relationship with PD, progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and dementia with Lewy bodies (DLB). Our results suggest that copy number polymorphisms within this region are not responsible for the H1 effect. However, we found a significant overrepresentation of H1 carriers in DLB patients, thus expanding the biological relevance of the haplotype in neurodegenerative disorders. We also examined the levels of circulating cell-free mitochondrial DNA in cerebrospinal fluid (CSF) and its utility as an indicator of mitochondrial dysfunction in the AD continuum. Although its measurement is reliable, the considerable inter-individual variability within groups limits its accuracy and usefulness as a diagnostic biomarker. Finally, we investigated the expression profile of microRNAs, a class of non-coding RNAs involved in the post-transcriptional modulation of gene expression, contained in extracellular vesicles (EVs) from CSF in FTD and other related syndromes. Numerous microRNAs can be detected within EVs from CSF. Moreover, we identified four microRNAs with a specific expression pattern in patients diagnosed with 4R-tau FTD syndromes.
APA, Harvard, Vancouver, ISO, and other styles
3

Arnold, Alexander [Verfasser]. "Genomweite molekulargenetische Untersuchung von DNA Copy Number Variations (CNVs) in cholangiozellulären Karzinomen / Alexander Arnold." Berlin : Medizinische Fakultät Charité - Universitätsmedizin Berlin, 2016. http://d-nb.info/1112552928/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Tervasmäki, A. (Anna). "Hereditary predisposition to breast cancer:evaluating the role of rare copy number variant, protein-truncating and missense candidate alleles." Doctoral thesis, Oulun yliopisto, 2018. http://urn.fi/urn:isbn:9789526220826.

Full text
Abstract:
Abstract Breast cancer is the most common cancer among women, and inherited predisposition is one of the major recognized causes of increased breast cancer risk. Only about half of the hereditary cases are explained by mutations in the known susceptibility genes, including the DNA damage response genes BRCA1, BRCA2 and PALB2, leaving the majority still uncovered. Identification of the missing genetic predisposing factors is important for more effective diagnostics and counseling of the risk families, and also for better understanding of the etiology and cellular characteristics of breast cancer. The first aim of this study was to investigate the cancer associations of six rare germline copy number variant (CNV) deletions, which were previously identified in breast cancer patients by a genome-wide microarray approach. The second aim was to identify novel susceptibility alleles, both protein-truncating variants and missense mutations, by next-generation sequencing (NGS) of nearly 800 DNA damage response genes in 189 hereditary breast cancer patients. The cancer-associations of all selected candidate alleles (6 CNVs, 39 protein-truncating variants and 35 missense mutations) were studied by case-control approach using DNA samples from several hundred breast cancer patients and healthy controls. The prevalence of the studied CNVs did not significantly differ between the cases and controls, but when studying the associations with specific clinical parameters, deletion in the CYP2C19 gene showed enrichment in the breast cancer patients with hormonally triple-negative tumors (p=0.021). As CYP2C19 functions in estrogen metabolism, the results indicate that disturbance of hormonal balance due to enzyme defects may predispose specifically to the estrogen receptor-negative subtype of breast cancer. Two protein truncating-variants, TEX15 c.7253dupT and FANCD2 c.2715+1G>A showed significant breast cancer association in the Northern Finnish cohort (p=0.018 and p=0.036, respectively). Similarly, two of the studied missense variants, RECQL p.Ile156Met (p=0.043) and POLG p.Leu392Val (p=0.010), were enriched in the breast cancer cases. Thus, this study provided novel connections between increased breast cancer risk and inherited mutations in TEX15, FANCD2 and POLG genes, and further supported the recently established role of RECQL as a breast cancer susceptibility gene
Tiivistelmä Rintasyöpä on naisten yleisin syöpä, ja perinnöllinen alttius on yksi merkittävimmistä sairastumisriskiin vaikuttavista tekijöistä. Tunnetuimpia alttiustekijöitä ovat mutaatiot BRCA1-, BRCA2- ja PALB2-DNA-vauriovastegeeneissä, mutta ne yhdessä muiden altistavien geenimutaatioiden kanssa selittävät kuitenkin vain noin puolet perinnöllisistä rintasyöpätapauksista. Uusien alttiusgeenien löytäminen mahdollistaa tehokkaamman diagnostiikan ja korkeassa syöpäriskissä olevien sukujen perinnöllisyysneuvonnan, sekä auttaa ymmärtämään syvemmin rintasyövän etiologiaa ja syntymekanismeja solutasolla. Tämän väitöskirjan ensimmäisenä päämääränä oli tutkia tarkemmin aiemmin genominlaajuisella mikrosirumenetelmällä rintasyöpäpotilailta tunnistettujen harvinaisten perinnöllisten DNA-kopiolukuvariaatioiden (CNV) yhteyttä rintasyöpäriskiin. Toisena tavoitteena oli tunnistaa uusia rintasyöpäalttiusalleeleja, sekä proteiinitrunkaatioita että missense-mutaatioita, hyödyntämällä uuden sukupolven sekvensointitekniikkaa, jonka avulla tutkittiin mutaatioita lähes 800 DNA-vauriovastegeenistä 189 pohjoissuomalaiselta rintasyöpäpotilaalta. Valittujen kandidaattialleelien (6 deleetion aiheuttavaa CNV:tä, 39 proteiinitrunkaatiota ja 35 missense-mutaatiota) yhteyttä rintasyöpään tutkittiin tapaus-verrokkimenetelmällä käyttäen DNA-näytteitä usealta sadalta rintasyöpäpotilaalta ja terveeltä kontrollihenkilöltä. Tutkittujen CNV:iden esiintyvyydessä ei ollut merkitseviä eroja potilaiden ja kontrollien välillä, mutta tarkasteltaessa yhteyttä potilaiden kasvaimista saatuihin kliinisiin parametreihin, deleetio CYP2C19-geenissä oli yleisempi hormonaalisesti kolmoisnegatiivisissa rintatuumoreissa kuin muissa tuumorityypeissä (p=0.021). Koska CYP2C19 on estrogeenimetaboliaan osallistuva entsyymi, sen viallinen toiminta voi mahdollisesti altistaa erityisesti estrogeenireseptorinegatiiviselle rintasyövälle. Kaksi tutkituista proteiinitrunkaatioista, TEX15 c.7253dupT ja FANCD2 c.2715+1G>A, olivat rikastuneet perinnöllisessä rintasyöpäpotilasaineistossa verrattuna kontrolleihin (p=0.018 ja p=0.036). Myös kaksi missense-alleelia, RECQL p.Ile156Met (p=0.043) ja POLG p.Leu392Val (p=0.010), olivat yleisempiä rintasyöpäpotilailla. Tulokset osoittivat uuden yhteyden kohonneen rintasyöpäriskin ja perinnöllisten muutosten TEX15-, FANCD2- ja POLG-geenien välillä, sekä tukivat aiempia tutkimustuloksia, joiden mukaan RECQL on kohtalaisen riskin rintasyöpäalttiusgeeni
APA, Harvard, Vancouver, ISO, and other styles
5

Hull, Ryan. "Accelerated adaptation through stimulated copy number variation in Saccharomyces cerevisiae." Thesis, University of Cambridge, 2018. https://www.repository.cam.ac.uk/handle/1810/284381.

Full text
Abstract:
Accelerated Adaptation through Stimulated Copy Number Variation in Saccharomyces cerevisiae Ryan Matthew Hull Repetitive regions of the genome, such as the centromeres, telomeres and ribosomal DNA account for a large proportion of the genetic variation between individuals. Differences in the number of repeat sequences between individuals is termed copy number variation (CNV) and is rife across eukaryotic genomes. CNV is of clinical importance as it has been implicated in many human disorders, in particularly cancers where is has been associated with tumour growth and drug resistance. The copper-resistance gene CUP1 in Saccharomyces cerevisiae is one such CNV gene. CUP1 is transcribed from a copper inducible promoter and encodes a protein involved in copper detoxification. In this work I show that yeast can regulate their repeat levels of the CUP1 gene through a transcriptionally stimulated CNV mechanism, as a direct adaptation response to a hostile environment. I characterise the requirement of the epigenetic mark Histone H3 Lysine 56 acetylation (H3K56ac) for stimulated CNV and its limitation of only working at actively transcribed genes. Based upon my findings, I propose a model for how stimulated CNV is regulated in yeast and show how we can pharmacologically manipulate this mechanism using drugs, like nicotinamide and rapamycin, to stimulate and repress a cell's ability to adapt to its environment. I further show that the model is not limited to high-copy CUP1 repeat arrays, but is also applicable to low-copy systems. Finally, I show that the model extends to other genetic loci in response to different challenging environments, such as formaldehyde stimulation of the formaldehyde-resistance gene SFA1. To the best of our knowledge, this is the first example of any eukaryotic cell undergoing genome optimisation as a novel means to accelerate its adaptation in direct response to its environment. If conserved in higher eukaryotes, such a mechanism could have major implications in how we consider and treat disorders associated with changes in CNV.
APA, Harvard, Vancouver, ISO, and other styles
6

Konyukh, Marina. "Copy number variations in autism spectrum disorders : identification and characterization of new candidate genes ( SEZ6L2 ans CNTN3-6)." Paris 7, 2010. http://www.theses.fr/2010PA077235.

Full text
Abstract:
Les troubles du spectre autistique (TSA) sont caractérisés par un déficit de la communication sociale et des comportements stéréotypés. Des études d'agrégation familiales et sur les jumeaux ont indiqué que les TSA ont une composante génétique forte. Récemment, l'étude du génome à grande échelle et à haute résolution a révélé des variations du nombre de copies (CNV). Un des CNV les plus fréquemment observés chez les patients atteints de TSA est la délétion/duplication localisée dans la région chromosomique 16pl 1. 2. Parmi les gènes situés dans ce CNV, des analyses montre que SEZ6L2, pourrait être associé aux TSA. J'ai recherché des mutations dans SEZ6L2 sur un group de 170 patients et sur un panel de 282 personnes de différentes origines ethniques. J'ai trouvé des variations qui sont prédites comme ayant un impact sur la fonction de la protéine, mais ne montrant aucun enrichissement significatif chez les patients comparé aux témoins. J'ai été impliquée dans L'analyse des CNV du génome entier pour des patients atteints de TSA (n=347) et pour des contrôles (n=338). J'ai pu détecter les CNV dans des gènes candidats potentiels, notamment dans les contactines, de protéines impliquées dans le guidage axonal et dans la connexion entre les axones et les cellules gliales. J'ai séquence la partie codante des gènes CNTN3-6 et CNTNAP2 dans des groupes patients et contrôles et j'ai pu identifier des variations rares et une mutation non-sens dans des familles avec TSA. Nos données in vitro, suggèrent que plusieurs variations ont pour conséquence une altération de la morphologie des neurones. Ces résultats confirment le câblage anormal du cerveau comme un facteur de risque pour les TSA
Autism spectrum disorders (ASD) are characterised by impaired reciprocal social communication, and stereotyped behaviour. Twin and familial studies have indicated that ASD are among the most genetic neuropsychiatric disorders. Recently, large-scale and high-resolution genome wide analyses revealed multiple copy number variations (CNV). Among the more frequently observed CNV associated with ASD are deletions/duplications, located on chromosome 16pl 1. 2. A primary analysis indicated that SEZ6L2 gene could be associated with ASD. During my thesis, I first screened for mutations in SEZ6L2 in a sample of 170 patients with ASD and in a panel of 282 individuals from different ethnic backgrounds. I was able to find mutations predicted as deleterious, but no significant enrichment compared with controls. I was also involved in the whole genome CNV screening of a large group of ASD patients (n=347) and controls (n=338). Using genome wide analysis, I could detect CNV altering compelling candidate genes. We could identify CNV altering several members of the contactins, a family of proteins involved in axonal guidance and the connection between axons and glial cells. I then screened for coding variations in CNTN3-6 and CNTNAP2. This screening revealed rare variants and a stop mutation present in ASD families. Our in vitro studies suggested that several variations had a functional consequence on neuronal morphology. These results further support abnormal brain wiring as a risk factor for ASD
APA, Harvard, Vancouver, ISO, and other styles
7

Molck, Miriam Coelho 1985. "Investigação de variações no número de cópias do DNA (Copy Number Variations, CNVs) em pacientes com suspeita clínica da Síndrome Velocardiofacial." [s.n.], 2015. http://repositorio.unicamp.br/jspui/handle/REPOSIP/313122.

Full text
Abstract:
Orientadores: Vera Lúcia Gil da Silva Lopes, Milena Simioni
Tese (doutorado) - Universidade Estadual de Campinas, Faculdade de Ciências Médicas
Made available in DSpace on 2018-08-27T18:40:32Z (GMT). No. of bitstreams: 1 Molck_MiriamCoelho_D.pdf: 5956023 bytes, checksum: 07a0d65667a7a002b0e8ad7a872c0d31 (MD5) Previous issue date: 2015
Resumo: A Síndrome Velocardiofacial (SVCF) tem prevalência de ~1:4.000 nascimentos e apresenta espectro fenotípico variável, incluindo defeitos cardíacos congênitos (DCC). Microdeleções de ~3 Mb em 22q11.2 representam a principal causa, entretanto deleções atípicas nesta região têm sido relatadas, assim como fenótipos similares associados a variações no número de cópias do DNA (Copy number variations, CNVs) em outras regiões cromossômicas. Esta proposta objetiva mapear os pontos de quebra da região 22q11.2 e investigar CNVs em outras regiões do genoma em pacientes com a deleção 22q11.2 confirmada previamente (Grupo I) e investigar CNVs no genoma de pacientes sem a deleção 22q11.2 (Grupo II). Foram investigados 108 pacientes (30 do Grupo I e 78 do Grupo II) com suspeita clínica da SVCF e DCC por Hibridação Genômica em arrays (array Genomic Hybridization- aGH). Para o Grupo I, o tamanho da deleção 22q11.2 proximal variou de 1,8 Mb a 3,3 Mb em 28 casos, sendo que um apresentou a deleção entre as LCRs (Low Copy Repeats) A-B e os demais 27 entre as LCRs A-D (região tipicamente deletada). Dois casos apresentaram deleções atípicas em 22q11.2: 3,6 Mb entre as LCRs B-F, elvolvendo as regiões 22q11.2 proximal e distal; e 1,5 Mb entre as LCRs D-E, envolvendo a região 22q11.2 distal. Além disso, foram observadas dez CNVs ? 300 kb relevantes fora da região 22q11.2, incluindo uma deleção em 11q14.3 e duplicações em 2q24.1-q24.2, 3p22.1, 5p15.2, 5q11.1, 6p21.2, 7p11.2, 15q13.3, 16q23.3 e Xp21.1. Para o Grupo II, foi observado um total de 25 CNVs ? 300 Kb relevantes. Destas, nove CNVs já foram descritas na literatura, incluindo deleções em 4q35.1-q35.2, 5p15.1-p15.33, 8p23.1, 10q22.3-q23.2, 16p11.2, 17q12 e 22q13.33; e duplicações em 3p26.3 e 3q26.2. As variações gênicas dentro dos pontos de quebra da região deletada 22q11.2, bem como as CNVs observadas em outras regiões cromossômicas contribuem para a variabilidade fenotípica observada nesta síndrome e confirmam a sobreposição desta com diferentes condições clínicas
Abstract: The Velocardiofacial Syndrome (VCFS) has a prevalence of ~1:4.000 births and shows variable phenotypic spectrum, including congenital heart defects (CHD). Microdeletions of ~3 Mb in 22q11.2 represent the main cause, however atypical deletions in this region have been reported, as well as similar phenotypes associated with changes in the number of DNA copies (Copy number variations, CNVs) in other chromosomal regions. This work aims to map the breakpoints of the 22q11.2 region and investigate CNVs in other regions of the genome in patients with the 22q11.2 deletion previously confirmed (Group I) and investigate CNVs on the genome of patients without the 22q11.2 deletion (Group II). We investigated 108 patients (30 from Group I and 78 from Group II) with clinical suspicion of VCFS and CHD for array Genomic Hybridization (aGH). For Group I, the size of proximal 22q11.2 deletion ranged from 1.8 Mb to 3.3 Mb in 28 cases, of these, one case had the deletion between LCRs (Low Copy Repeats) A-B and the other 27 between LCRs A-D (typically deleted region). Two cases had atypical deletions at 22q11.2: 3.6 Mb between LCRs B-F, involving proximal and distal 22q11.2 regions; and 1.5 Mb between LCRs D-E, involving distal 22q11.2 region. Additionally, we observed ten relevant CNVs ? 300 kb outside of 22q11.2 region, including a deletion in 11q14.3 and duplications in 2q24.1-q24.2, 3p22.1, 5p15.2, 5q11.1, 6p21.2, 7p11.2, 15q13.3, 16q23.3 and Xp21.1. For Group II, a total of 25 relevant CNVs ? 300 Kb was observed. Of these, nine CNVs have been described in the literature, including deletions in 4q35.1-q35.2, 5p15.1-p15.33, 8p23.1, 10q22.3-q23.2, 16p11.2, 17q12 and 22q13.33; and duplications in 3p26.3 and 3q26.2. Gene variations within the break points of the 22q11.2 deleted region and CNVs observed in other chromosomal regions contribute to phenotypic variability observed in this syndrome and confirm the overlapp with different clinical conditions
Doutorado
Ciencias Biomedicas
Doutora em Ciências Médicas
APA, Harvard, Vancouver, ISO, and other styles
8

Karcanias, Alexandra. "Investigation of genomic DNA copy number variation on the human sex chromosomes associated with genetic pathologies." Thesis, University of Cambridge, 2008. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.612017.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

DeConti, Derrick K. "Systematic Analysis of Duplications and Deletions in the Malaria Parasite P. falciparum: A Dissertation." eScholarship@UMMS, 2004. http://escholarship.umassmed.edu/gsbs_diss/869.

Full text
Abstract:
Duplications and deletions are a major source of genomic variation. Duplications, specifically, have a significant impact on gene genesis and dosage, and the malaria parasite P. falciparum has developed resistance to a growing number of anti-malarial drugs via gene duplication. It also contains highly duplicated families of antigenically variable allelic genes. While specific genes and families have been studied, a comprehensive analysis of duplications and deletions within the reference genome and population has not been performed. We analyzed the extent of segmental duplications (SD) in the reference genome for P. falciparum, primarily by a whole genome self alignment. We discovered that while 5% of the genome identified as SD, the distribution within the genome was partition clustered, with the vast majority localized to the subtelomeres. Within the SDs, we found an overrepresentation of genes encoding antigenically diverse proteins exposed to the extracellular membrane, specifically the var, rifin, and stevor gene families. To examine variation of duplications and deletions within the parasite populations, we designed a novel computational methodology to identify copy number variants (CNVs) from high throughput sequencing, using a read depth based approach refined with discordant read pairs. After validating the program against in vitro lab cultures, we analyzed isolates from Senegal for initial tests into clinical isolates. We then expanded our search to a global sample of 610 strains from Africa and South East Asia, identifying 68 CNV regions. Geographically, genic CNV were found on average in less than 10% of the population, indicating that CNV are rare. However, CNVs at high frequency were almost exclusively duplications associated with known drug resistant CNVs. We also identified the novel biallelic duplication of the crt gene – containing both the chloroquine resistant and sensitive allele. The synthesis of our SD and CNV analysis indicates a CNV conservative P. falciparum genome except where drug and human immune pressure select for gene duplication.
APA, Harvard, Vancouver, ISO, and other styles
10

DeConti, Derrick K. "Systematic Analysis of Duplications and Deletions in the Malaria Parasite P. falciparum: A Dissertation." eScholarship@UMMS, 2015. https://escholarship.umassmed.edu/gsbs_diss/869.

Full text
Abstract:
Duplications and deletions are a major source of genomic variation. Duplications, specifically, have a significant impact on gene genesis and dosage, and the malaria parasite P. falciparum has developed resistance to a growing number of anti-malarial drugs via gene duplication. It also contains highly duplicated families of antigenically variable allelic genes. While specific genes and families have been studied, a comprehensive analysis of duplications and deletions within the reference genome and population has not been performed. We analyzed the extent of segmental duplications (SD) in the reference genome for P. falciparum, primarily by a whole genome self alignment. We discovered that while 5% of the genome identified as SD, the distribution within the genome was partition clustered, with the vast majority localized to the subtelomeres. Within the SDs, we found an overrepresentation of genes encoding antigenically diverse proteins exposed to the extracellular membrane, specifically the var, rifin, and stevor gene families. To examine variation of duplications and deletions within the parasite populations, we designed a novel computational methodology to identify copy number variants (CNVs) from high throughput sequencing, using a read depth based approach refined with discordant read pairs. After validating the program against in vitro lab cultures, we analyzed isolates from Senegal for initial tests into clinical isolates. We then expanded our search to a global sample of 610 strains from Africa and South East Asia, identifying 68 CNV regions. Geographically, genic CNV were found on average in less than 10% of the population, indicating that CNV are rare. However, CNVs at high frequency were almost exclusively duplications associated with known drug resistant CNVs. We also identified the novel biallelic duplication of the crt gene – containing both the chloroquine resistant and sensitive allele. The synthesis of our SD and CNV analysis indicates a CNV conservative P. falciparum genome except where drug and human immune pressure select for gene duplication.
APA, Harvard, Vancouver, ISO, and other styles
11

Park, Chrisopher Changsun. "Fine mapping of regulatory loci for mammalian gene expression via induced DNA copy number variation in radiation hybrids." Diss., Restricted to subscribing institutions, 2009. http://proquest.umi.com/pqdweb?did=1872924251&sid=1&Fmt=2&clientId=1564&RQT=309&VName=PQD.

Full text
APA, Harvard, Vancouver, ISO, and other styles
12

Derhourhi, Mehdi. "Nouvelle technique de détection simultanée des variant ponctuels et des copy number variants dans l’obésité monogénique." Thesis, Lille 2, 2018. http://www.theses.fr/2018LIL2S029/document.

Full text
Abstract:
La génétique, et par extension le séquençage de l’ADN, sont des outils qui ont transformé la compréhension des mécanismes impliqués dans la survenue de nombreuses pathologies, dont l’obésité. Les technologies aujourd’hui à notre disposition nous permettent de déterminer rapidement si un patient est ou non porteur d’un évènement génétique pouvant expliquer sa pathologie. L’une des techniques les plus utilisées en diagnostic aujourd’hui est le séquençage d’exome, ou WES, qui permet une excellente détection des mutations ponctuelles dans les régions codantes du génome. Mais d’autres évènements comme les copy number variants, ou CNV, peuvent également expliquer certaines pathologies, dont l’obésité, via entre autres les CNV de la région 16p11.2. Actuellement, la technique de référence pour la détection de ces copy number variants est l’analyse de puces CGH (Comparative Genomic Hybridization), mais celles-ci ne permettent pas de détecter des mutations non répertoriées au préalable lors de la création de la puce. Sur le principe, le séquençage d’exome peut lui aussi être utilisé pour détecter les CNV, mais son absence de couverture des régions non codantes du génome ne permet pas une détection efficace de ces CNV, car ceux-ci peuvent survenir sur l’ensemble du génome, en englobant des régions codantes et non codantes au sein d’un seul évènement. Le séquençage génome complet peut détecter ces deux types d’évènement, mais son cout est encore élevé ce qui freine sa démocratisation, et l’analyse de données associées nécessite d’importantes ressources informatiques, et le rend difficilement utilisable en diagnostic de routine en l’état actuel des choses. Il est donc pour l’instant nécessaire d’avoir recours à deux techniques différentes pour couvrir ces deux types d’évènements génétiques. Cela implique d’utiliser des échantillons parfois très précieux à deux reprises, de supporter les couts liés à deux techniques diagnostiques (d’environ 450 euros pour le séquençage d’exome au laboratoire et un cout un peu plus élevé pour une puce à ADN dans un laboratoire clinique), et d’allonger les temps de rendu de résultats et donc la durée d’établissement du diagnostic du patient. Cet état de fait nous a conduit à développer une technique de séquençage, que nous avons nommé CoDE-seq (Copy number variation Detection and Exome sequencing), et qui permettra la détection simultanée de ces deux types d’évènements, pour diminuer les temps d’établissement de diagnostics, leurs couts, et la quantité d’échantillon nécessaire. Ce travail a nécessité deux aspects : la mise au point technique et la mise au point analytique. La mise au point technique est passée par la création d’une nouvelle « capture », permettant une détection correcte des mutations ponctuelles de l’exome et des CNV de tout le génome. La mise au point analytique a consisté à définir la méthode à employer, et à permettre d’arriver à une détection fiable, à la fois sensible et spécifique, des CNV sur l’ensemble du génome. Une fois ces CNV identifiés, la question de leur signification fonctionnelle se pose également, et une seconde partie de ma thèse porte sur l’étude de cette signification fonctionnelle, via l’étude de la conformation spaciale de la chromatine et de l’influence des CNV sur celle-ci
Genetics, and by extention DNA sequencing, are tools that have modified the understanding of the mechanisms involved in genetic diseases, like obesity. Today’s technology has allowed us to rapidly find if a patient carries a genetic event that may explain his/her pathology. One of the most used technology for diagnostic is exome sequencing, or WES, which enables an excellent detection of point mutations in coding regions of the genome. However other events, such as copy number variations, or CNV, can also explain some pathologies, like a severe form of obesity due to CNV in the chr16p11.2 region. Actually, the gold standard method for an accurate detection of CNV is array CGH, but this technology cannot detect new point mutations. Exome sequencing can be used to detect CNV, but the lack of coverage in non-coding regions limits CNV detection sensitivity. Of note, whole genome sequencing can detect both CNVs and point mutations, but it is still very expensive and needs huge informatics capacities, which is an obvious limitation for a routine diagnostic use.For now, we have had to use two different methods in order to accurately detect both CNVs and point mutations. In other words, we have had to use precious samples two times, to assume the cost of two different methods (which is nearly 450 euros in the laboratory for exome sequencing, and a bit more for array CGH in a clinical laboratory), and to consider the time of the realization of two different methods in order to achieve a complete diagnostic.In this context, we aimed to develop an innovative sequencing method, named CoDE-seq (Copy number variation Detection and Exome sequencing), which would allow us to simultaneously detect both CNVs and point mutations, in order to reduce the time of diagnostic, the cost, and the needed quantity of sample.This work included the method conception, and the data analysis steps. The method conception has been done through the creation of a new capture enabling the detection of point mutations in the exome, and CNVs all along the genome. Furthermore, the data analysis step included the choice of the bioinformatics methods to be used, in order to get a specific and sensitive CNV detection, all along the genome.We were also interested in the fonctional significance of identified CNV, and tried to decipher it by the study of chromatine spacial conformation and the influence of these CNV
APA, Harvard, Vancouver, ISO, and other styles
13

Henrique, Pamela Pontes 1990. "Investigação de microrrearranjos no cromossomo X pela técnica de MLPA em indivíduos do sexo masculino com deficiência intelectual de causa indeterminada." [s.n.], 2015. http://repositorio.unicamp.br/jspui/handle/REPOSIP/312507.

Full text
Abstract:
Orientadores: Antonia Paula Marques de Faria, Maricilda Palandi de Mello
Dissertação (mestrado) - Universidade Estadual de Campinas, Faculdade de Ciências Médicas
Made available in DSpace on 2018-08-30T05:34:46Z (GMT). No. of bitstreams: 1 Henrique_PamelaPontes_M.pdf: 8320960 bytes, checksum: 1d8ff3e1253bf81cc18b4afd51572860 (MD5) Previous issue date: 2015
Resumo: A deficiência intelectual ligada ao X (DILX) é uma das causas genéticas mais frequentes de deficiência intelectual (DI), ocorrendo em 10 a 12% de todos os homens afetados, provavelmente pelo maior número de genes identificados no cromossomo X em comparação a qualquer segmento autossômico. Cerca de 100 genes seriam determinantes de DILX, porém mesmo com o conhecimento do papel de vários deles, há aspectos a serem elucidados, como a contribuição de cada um na determinação da DI ou ainda as correlações genótipo-fenótipo, cuja análise depende da investigação genética em indivíduos com DI idiopática. Entre os métodos que permitem a investigação molecular dessa condição destaca-se a Multiplex Ligation-dependent Probe Amplification (MLPA) por sua rapidez, sensibilidade e baixo custo. O objetivo do presente estudo foi investigar alterações em genes do cromossomo X pela técnica de MLPA em pacientes do sexo masculino com atraso global do desenvolvimento ou DI de origem indeterminada. Foram investigados 107 indivíduos com o kit SALSA MLPA P106 MRX probemix (MRC-Holland), 104 deles apresentaram resultado na faixa de normalidade e em três foram identificadas alterações do número de cópias interpretadas como duplicações. O paciente P13 apresentou alteração no gene HUWE1, que atua no controle da diferenciação neural e tem mutações descritas em algumas famílias com DI de moderada a grave; no paciente P139 foram identificadas alterações nos genes SCL6A8 e GDI, ambas confirmadas pela análise por Real Time Polymerase Chain Reaction (qPCR); mutações no primeiro são incluídas entre as síndromes de deficiência de creatina, com fenótipos variando de DI leve e atraso de fala até DI grave, convulsões e alterações de comportamento no sexo masculino, enquanto no segundo se associam à DILX inespecífica; já no paciente P39 foi detectada alteração no gene ARX, relacionado a mais de uma condição classificada como DILX sindrômica, que não foi confirmada. Como apenas alguns éxons relacionados à DILX foram investigados, não se afasta a eventual ocorrência de rearranjos localizados em regiões não abordadas pelo kit utilizado. Contudo, a técnica utilizada se mostrou uma opção de custo relativamente baixo e fácil reprodutibilidade, sendo viável para aplicação em algoritmos de investigação da DI. Os resultados reforçam a relevância da DILX entre as causas de DI, justificando a inclusão de testes moleculares específicos para a elucidação diagnóstica dessa condição
Abstract: X-linked intellectual disability (XLID) is one of the most frequent genetic causes of intellectual disability (ID), occurring in 10-12% of all affected men, probably because the larger number of identified genes on the X chromosome related to this condition than in any other autosomal segment. Although about 100 genes have been considered as determinant of XLID, the the role of several of these genes remains yet be elucidated despite the knowledge on the function of several of them. For instance, the contribution of each gene in determining the ID and the genotype-phenotype correlation depend on the genetic investigation of affected individuals. The Multiplex Ligation-dependent Probe Amplification (MLPA) is among the methods that allow molecular investigation of this condition because it is rapid and low cost and presents high sensitivity. The aim of this study was to investigate copy number variations in X-linked genes by MLPA technique in males with global developmental delay or ID of undetermined origin. A hundred and seven individuals were investigated using SALSA MLPA P106 MRX kit (MRC-Holland) and alterations were confirmed by Real Time Polymerase Chain Reaction (qPCR). A normal invariant pattern was observed in 104 out of 107 individuals, and three showed variations that have been interpreted as duplications. Patient P13 showed increased signal for HUWE1 gene, which plays a role in the control of neural differentiation. HUWE1 mutations have been described in families with moderate or severe ID. Patient P139 showed increased signals corresponding to regions of SCL6A8 and GDI1 genes. The former is included among genes involved in the creatine deficiency syndrome whose phenotype can range from mild ID and speech delay to severe ID, convulsions and behavior changes in males, and the latter is involved with non-syndromic XLID. Conversely, the variation in ARX gene, which is associated to more than one condition classified as syndromic XLID, observed in MLPA analysis for patient P39 was not confirmed in the qPCR assay. As only a few exons related to XLID were investigated, it does not rule out the possible occurrence of rearrangements located in regions not covered by the kit used. However, the technique employed was an easily reproducible, relatively low cost option, manageable for application in ID research algorithms. The results reinforce the importance of XLID among the causes of ID, justifying the inclusion of specific molecular tests for the laboratory diagnosis of this condition
Mestrado
Ciencias Biomedicas
Mestra em Ciências Médicas
APA, Harvard, Vancouver, ISO, and other styles
14

Zhang, Ke. "Inference of nonparametric hypothesis testing on high dimensional longitudinal data and its application in DNA copy number variation and micro array data analysis." Diss., Manhattan, Kan. : Kansas State University, 2008. http://hdl.handle.net/2097/1105.

Full text
APA, Harvard, Vancouver, ISO, and other styles
15

Vuorela, M. (Mikko). "Role of the RNF8, UBC13, MMS2 and RAD51C DNA damage response genes and rare copy number variants in hereditary predisposition to breast cancer." Doctoral thesis, Oulun yliopisto, 2013. http://urn.fi/urn:isbn:9789526203096.

Full text
Abstract:
Abstract Mutations in the currently known breast cancer susceptibility genes account for only 25–30% of all familial cases. Novel susceptibility genes can be identified by several methods, including candidate gene re-sequencing and genome-wide microarrays. We have applied microarrays for the detection of a new genomic variation class, copy number variants (CNVs), which potentially could disrupt genes in multiple pathways related to breast cancer susceptibility. The aim of the current study was to evaluate the role of the RNF8, UBC13, MMS2 and RAD51C DNA damage response genes in breast cancer susceptibility as well as to study if rare CNVs are associated with the predisposition to this disease. The analysis of 123 familial breast cancer cases revealed altogether nine different changes in the RNF8 and UBC13 candidate genes. However, none of the observed alterations were considered pathogenic. No alterations were observed in MMS2. The obtained results suggest that breast cancer predisposing alterations in RNF8, UBC13 and MMS2 are rare, or even absent. The RAD51C mutation screening of 147 familial breast cancer cases and 232 unselected ovarian cancer cases revealed two deleterious mutations: c.-13_14del27 was observed in a breast cancer case with familial history of ovarian cancer and c.774delT in an ovarian cancer case. Both mutations were absent in the control cohort. The results of the study support the hypothesis that rare variants of RAD51C predispose predominantly to ovarian cancer. A genome-wide scan of CNVs was performed for 103 familial breast cancer cases and 128 controls. The biological networks of the genes disrupted by CNVs were different between the two groups. In familial breast cancer cases, the observed mutations disrupted genes, which were significantly overrepresented in cellular functions related to maintenance of genomic integrity (P=0.0211). Biological network analysis showed that the disrupted genes were closely related to estrogen signaling and TP53-centered tumor suppressor network, and this result was confirmed by the analysis of an independent young breast cancer cohort of 75 cases. These results suggest that rare CNVs represent an alternative source of genetic variation contributing to hereditary risk for breast cancer
Tiivistelmä Tunnetut rintasyöpäalttiusgeenien mutaatiot selittävät vain 25–30 prosenttia kaikista perinnöllisistä rintasyöpätapauksista. Uusia alttiusgeenejä voidaan tunnistaa useilla eri menetelmillä, kuten kandidaattigeenien mutaatiokartoituksella ja genomin-laajuisilla mikrosirutekniikoilla. Tässä tutkimuksessa sovelsimme mikrosirutekniikkaa uuden geneettisen variaatioluokan, kopiolukuvariaation (CNV), tutkimiseen. CNV:t voivat vaurioittaa lukuisia rintasyöpäalttiuteen liittyviä biokemiallisia reittejä. Tämän tutkimuksen tarkoitus oli arvioida RNF8-, UBC13-, MMS2- ja RAD51C -DNA- vauriovastegeenien sekä harvinaisten CNV:iden yhteyttä rintasyöpä-alttiuteen. 123 familiaalisen rintasyöpätapauksen analyysissä löytyi yhteensä yhdeksän muutosta RNF8- ja UBC13-geeneistä, joista yksikään ei osoittautunut patogeeniseksi. MMS2-geenissä ei havaittu muutoksia. Tulosten perusteella rintasyövälle altistavat muutokset RNF8-, UBC13- ja MMS2- geeneissä ovat joko erittäin harvinaisia tai niitä ei esiinny lainkaan. RAD51C-geenin mutaatiokartoitus 147 familiaalisesta rintasyöpätapauksesta sekä 232 valikoimattomasta munasarjasyöpätapauksesta paljasti kaksi haitallista mutaatiota. c.-13_14del27 havaittiin rintasyöpäpotilaalla, jonka suvussa esiintyi munasarjasyöpää, ja c.774delT todettiin munasarjasyöpäpotilaalta. Kumpaakaan mutaatiota ei havaittu verrokkiaineistossa. Tulokset vahvistavat hypoteesia RAD51C-geenin harvinaisten varianttien yhteydestä pääasiassa munasarjasyöpäriskiin. CNV:iden genomin-laajuinen skannaaminen suoritettiin 103 familiaaliselle rintasyöpätapaukselle ja 128 verrokille. CNV:iden häiritsemien geenien muodostamat biologiset verkostot olivat erilaiset näiden kahden ryhmän välillä. Familiaalisilla rintasyöpätapauksilla havaitut CNV:t vaikuttivat geeneihin, jotka olivat voimakkaasti korostuneita genomin eheyttä ylläpitävissä tehtävissä (P=0.0211). Biologisten verkostojen analyysi paljasti, että CNV:iden vahingoittamat geenit liittyivät läheisesti estrogeenisignalointiin sekä TP53-tuumorisupressoriverkostoon, ja tämä tulos vahvistettiin analysoimalla riippumatonta nuorista rintasyöpäpotilaista koostuvaa kohorttia (N=75). Tutkimuksen tulosten mukaan harvinaiset CNV:t ovat vaihtoehtoinen geneettisen variaation lähde perinnölliseen rintasyöpäalttiuteen
APA, Harvard, Vancouver, ISO, and other styles
16

Campos, Carla Marques Rondon. "Investigação da variação no número de cópias gênicas em crianças com defeito cardíaco conotruncal." Universidade de São Paulo, 2014. http://www.teses.usp.br/teses/disponiveis/5/5141/tde-20102014-115515/.

Full text
Abstract:
INTRODUÇÃO: Os defeitos cardíacos congênitos (DCC) são um grupo de anormalidades estruturais mais prevalentes ao nascimento e uma das principais causas de morbidade e mortalidade infantil. Os fatores genéticos são importantes na etiologia dos DCC. Estudos têm mostrado a contribuição da variação no número de cópias (CNV) na gênese das malformações cardíacas. A deleção 22q11.2 é a causa mais comum de microdeleção humana e está relacionada com defeito cardíaco (DCC) conotruncal. O MLPA (Multiplex Ligation-dependent Probe Amplification) é um método eficaz para detectar microdeleções/microduplicações em pacientes com DCC. OBJETIVO: Detectar a presença da variação no número de cópias gênicas em pacientes portadores de cardiopatia conotruncal pela técnica de MLPA e associar ao fenótipo do paciente. MÉTODOS: Foram avaliados 39 pacientes (23 do sexo masculino, 16 do sexo feminino) com idade entre 2 dias e 19 anos (mediana de 6 anos), todos com cardiopatia conotruncal, a maioria dos pacientes (56%) apresentavam tetralogia de Fallot. Avaliação clínica e laboratorial foi realizada em todos os pacientes. O cariótipo foi normal em todos pacientes. MLPA foi realizada com os kits P064, P036/P070 e P250. RESULTADOS: Foram detectadas CNVs em sete pacientes: deleção 22q11.2, duplicação 22q11.2, duplicação 15q11.2, duplicação 20p12.2, deleção 19p, duplicação 15q e duplicação 8p23.2 com duplicação 10p12.31. As cardiopatias encontradas nestes pacientes foram: dupla via de saída de ventrículo direito (2), coartação da aorta, tetralogia de Fallot (3) e transposição de grandes artérias. Os achados clínicos extracardíacos encontrados nestes pacientes foram dismorfismo facial, dente neonatal, atrofia e displasia cerebral, atresia duodenal, dificuldade de aprendizado, insuficiência velofaríngea, aplasia de timo, refluxo gastroesofágico, hérnia umbilical, asma, infecções de vias aéreas frequente, déficit de crescimento e somente três apresentavam retardo no desenvolvimento neuropsicomotor (dup 15q11.2, dup 15q, del 22q11.2). As características clínicas foram compatíveis com o relatado na literatura associado com a microdeleção/microduplicação encontrada. Nenhuma destas alterações foram herdadas de seus pais testados em seis casos. CONCLUSÃO: O uso do MLPA possibilitou a detecção de CNVs em pacientes com DCC. O diagnóstico precoce das CNVs em pacientes com DCC auxilia na prevenção de morbidade e diminuição da mortalidade nestes pacientes, contudo em um país com regiões com poucos recursos laboratoriais genéticos uma avaliação clínica minuciosa em todo paciente com DCC é imprescindível para direcionar qual melhor exame deve ser realizado
INTRODUCTION: Congenital heart defects (CHD) are a group of structural abnormalities most prevalent birth and a major cause of infant morbidity and mortality. Genetic factors are important in the etiology of CHD. Studies have shown the contribution of copy number variation (CNV) in the genesis of cardiac malformations. The deleletion 22q11.2 is the most common cause of human microdeletion and is related conotruncal cardiac defect (DCC). The MLPA (Multiplex Ligation-dependent Probe Amplification) is an effective method to detect microdeletions/micoduplications in patients with CHD. PURPOSE: Detect the presence of gene copies number variation in the patients with conotruncal heart defect by MLPA technique and associate the phenotype of the patient. METHODS: 39 patients (23 males, 16 females) aged 2 days old - 19 years old (median= 6 years old) with conotruncal cardiac defect were evaluated. Tetralogy of Fallot was more prevalent heart defect (56%). All patients were evaluated clinical and laboratory. Karyotypes were normal in all pacients. MLPA was performed with the P064, P036/P070 and P250 kits. RESULTS: CNVs were detected in seven patients: 22q11.2 deletion, 22q11.2 duplication, 15q11.2 duplication, 20p12.2 duplication, 19p deletion, 15q duplication and 8p23.2 duplication with 10p12.31 duplication. The congenital heart defect found in these patients were: double outlet right ventricle (2), coarctation of the aorta, tetralogy of Fallot (3) and transposition of the great arteries. Clinical findings in these patients were facial dysmorphism, neonatal tooth, brain atrophy and dysplasia, duodenal atresia, learning disabilities, velopharyngeal insufficiency, thymic aplasia, gastroesophageal reflux, umbilical hernia, asthma, frequent infections of the airways , failure to thrive, and only three had delayed psychomotor development (dup 15q 11.2, dup 15q, del 22q11.2) The clinical features were consistent with those reported in the literature associated with the microdeletion /microduplication found. None of these alterations were inherited from six parents tested. CONCLUSIONS: MLPA was effective to detect CNVs in patients with CHD. Early diagnosis of CNVs in patients with CHD assists in preventing morbidity and decreased mortality in these patients, however, in a country with regions with few genetic laboratory resources a thorough clinical evaluation in all patients with CHD is essential to direct which should be further analyzed performed
APA, Harvard, Vancouver, ISO, and other styles
17

Rodrigues, Joana de Matos. "From genes to radioresistance in head and neck squamous cell carcinoma." Master's thesis, Universidade de Aveiro, 2015. http://hdl.handle.net/10773/16133.

Full text
Abstract:
Mestrado em Biomedicina Molecular
Head and Neck Cancers (HNC) are a group of tumours located in the upper aero-digestive tract. Head and Neck Squamous Cell Carcinoma (HNSCC) represent about 90% of all HNC cases. It has been considered the sixth most malignant tumour worldwide and, despite clinical and technological advances, the five-year survival rate has not improved much in the last years. Nowadays, HNSCC is well established as a heterogeneous disease and that its development is due to accumulation of genetic events. Apart from the majority of the patients being diagnosed in an advanced stage, HNSCC is also a disease with poor therapeutic outcome. One of the therapeutic approaches is radiotherapy. However, this approach has different drawbacks like the radioresistance acquired by some tumour cells, leading to a worse prognosis. A major knowledge in radiation biology is imperative to improve this type of treatment and avoid late toxicities, maintaining patient quality of life in the subsequent years after treatment. Then, identification of genetic markers associated to radiotherapy response in patients and possible alterations in cells after radiotherapy are essential steps towards an improved diagnosis, higher survival rate and a better life quality. Not much is known about the radiation effects on cells, so, the principal aim of this study was to contribute to a more extensive knowledge about radiation treatment in HNSCC. For this, two commercial cell lines, HSC-3 and BICR-10, were used and characterized resorting to karyotyping, aCGH and MS-MLPA. These cell lines were submitted to different doses of irradiation and the resulting genetic and methylation alterations were evaluated. Our results showed a great difference in radiation response between the two cell lines, allowing the conclusion that HSC-3 was much more radiosensitive than BICR-10. Bearing this in mind, analysis of cell death, cell cycle and DNA damages was performed to try to elucidate the motifs behind this difference. The characterization of both cell lines allowed the confirmation that HSC-3 was derived from a metastatic tumour and the hypothesis that BICR-10 was derived from a dysplasia. Furthermore, this pilot study enabled the suggestion of some genetic and epigenetic alterations that cells suffer after radiation treatment. Additionally, it also allowed the association of some genetic characteristics that could be related to the differences in radiation response observable in this two cell lines. Taken together all of our results contribute to a better understanding of radiation effects on HNSCC allowing one further step towards the prediction of patients’ outcome, better choice of treatment approaches and ultimately a better quality of life.
Cancro da Cabeça e Pescoço refere-se a um grupo de tumores que aparecem no trato aerodigestivo superior, sendo que o carcinoma das células escamosas da cabeça e pescoço (CCECP) corresponde a mais de 90% de todos os casos de cancro nesta região. Foi considerado o sexto tumor mais maligno em todo o mundo e, apesar de todos os avanços tecnológicos e clínicos, a taxa de sobrevivência a cinco anos não melhorou significativamente nas últimas décadas. Atualmente sabe-se que o CCECP é uma doença bastante heterogénea que se desenvolve devido à acumulação de alterações genéticas e epigenéticas. Alguns dos grandes problemas associados a este tipo de cancro são o diagnóstico em fase tardia da doença e os poucos resultados terapêuticos. Uma das escolhas terapêuticas para o CCECP é a radioterapia, no entanto, esta tem diversos inconvenientes, como a radioresistência adquirida por algumas células tumorais, que se associam a piores prognósticos. Um aumento do conhecimento na área da biologia da radiação é necessário para melhorar esta opção terapêutica, evitando futuros efeitos tóxicos e fornecendo uma melhor qualidade de vida nos anos subsequentes ao tratamento. Desta forma, a identificação de marcadores moleculares associados quer a uma resposta à radioterapia, quer a possíveis alterações celulares após tratamento com radiação, é essencial para melhorar o diagnóstico, taxa de sobrevivência e qualidade de vida destes doentes. Adicionalmente, existe uma grande falha no conhecimento em relação aos efeitos da radiação nas células, como tal, o principal objetivo deste estudo foi o de contribuir para um conhecimento mais alargado do efeito da radiação em doentes com CCECP. Para isso foram utilizadas duas linhas comerciais celulares, HSC-3 (derivada de um tumor metastático da língua) e BICR-10 (derivada de um tumor da mucosa bucal), que foram caracterizadas com recurso a aCGH, MS-MLPA e citogenética convencional. Estas linhas foram submetidas a diferentes doses de radiação e as alterações genéticas e de metilação pós tratamento foram determinadas. Estes resultados demonstraram uma grande variação de resposta à radiação para estas duas linhas celulares, permitindo a conclusão que a linha HSC-3 é mais radiossensível que a linha BICR-10. Tendo isto em mente, procedeu-se a análise da morte celular, ciclo celular e danos no DNA de forma a tentar compreender esta diferença. A caracterização genética de ambas as linhas celulares permitiu corroborar que a linha HSC-3 era derivada de um tumor metastático e sugeriu que a linha celular BICR-10 estaria associada a um estado de displasia. Para além disto, foi possível analisar alterações genéticas e epigenéticas ocorridas após irradiação e associar determinados perfis genéticos a uma melhor ou pior resposta à radiação. Em suma, os nossos resultados contribuiram para um conhecimento mais aprofundado dos efeitos da radiação no CCECP possibilitando, no futuro, melhores opções de tratamento e uma melhor qualidade de vida para estes doentes.
APA, Harvard, Vancouver, ISO, and other styles
18

Marques, Vanessa Alexandra Freire. "Genetic and epigenetic characterization of laryngeal carcinoma." Master's thesis, Universidade de Aveiro, 2015. http://hdl.handle.net/10773/15016.

Full text
Abstract:
Mestrado em Biomedicina Molecular
Laryngeal carcinomas belong to a bigger family of tumours known as Head and Neck Cancer (HNC). HNC is the sixth most malignant type of cancer in the world and it can arise from several anatomical sites. Among them, the larynx is the second most common affect organ. The incidence of laryngeal carcinoma is 1,9% worldwide and it presents a high mortality rate (1,6%). Despite technological advances in diagnosis and treatment fields, the 5 year-survival rate did not improved significantly. The low survival rates are mainly explained by a late diagnosis, tumour aggressiveness and the fact that laryngeal carcinoma metastasize easily. Taking this into consideration, it is essential to identify biomarkers with significant diagnostic and prognostic value in order to anticipate the detection of laryngeal carcinoma in an early stage. This study arises mainly for characterize the genetic and epigenetic profile of laryngeal squamous cell carcinoma (LSCC). Eight LSCC samples and seven non-tumour samples contralateral to the primary tumour were collected upon resection surgery and characterized by MLPA, MS-MLPA and array CGH. The results showed that gain of genetic material was mainly present in chromosomes 3q, 8q, 11q, 14q13.1, Xp22.31 and Xq21.1 while genetic loss occurred mainly in chromosomes 3p, 9p23.1 and Y. Gain of MYC and TNFRSF1A was the most common event among the tumour samples included in this study. Regarding the methylation profile, the genes CDKN2A, CHFR, RARβ e RASSF1 were the only ones which were methylated in this samples. In conclusion, this study allowed to identify genetic alterations associated with LSCC that have already been reported in scientific papers as well as alterations that have been associated with tumour development and progression. In addition, a few genetic alterations which have never been reported as being associated with human cancer before were identified. Nevertheless, new studies must be carried out, with a higher number of samples. Ultimately, the main goal would be to identify genetic alterations significantly associated with LSCC progression and establish a correlation with clinicopathological data.
O carcinoma da laringe pertence a uma grande família de tumores conhecida como Cancro da Cabeça e do Pescoço que é considerado o sexto tipo de tumor mais maligno em todo o mundo. Dentro desta família, os tumores podem ter origem em diversos locais anatómicos, sendo a laringe o segundo órgão mais comummente afetado. O cancro da laringe apresenta uma incidência mundial de 1,9% e uma taxa de mortalidade elevada de 1,6%. Apesar dos avanços tecnológicos na área do diagnóstico e da terapêutica, a taxa de sobrevivência ao fim de 5 anos não apresentou melhorias significativas. As baixas taxas de sobrevivências são explicadas essencialmente pelo diagnóstico tardio, pela agressividade do tumor e pela sua propensão a desenvolver metástases. Desta forma, torna-se essencial a identificação de biomarcadores com valor de diagnóstico e prognóstico a fim de detetar a presença do tumor numa fase mais precoce. Este estudo surge com o objetivo principal de caracterizar o perfil genético e epigenéticos do carcinoma das células escamosas da laringe com recurso às técnicas de MLPA, MS-MLPA e array CGH, usando oito amostras tumorais e sete amostras não-tumorais contra laterais ao tumor, ambas coletadas após cirurgia A análise genética revelou uma maior taxa de ganho de material genético nos cromossomas 3q, 8q, 11q, 14q13.1, Xp22.31, Xq21.1 e perda de material genético nos cromossomas 3p, 9p23.1 e Y. O ganho dos genes MYC e TNFRSF1A revelou ser o evento mais comum entre as amostras analisadas. Relativamente ao perfil epigenético, observou-se que os genes CDKN2A, CHFR, RARβ e RASSF1 se encontravam metilados nas amostras em estudo. Em suma, este trabalho permitiu identificar algumas alterações genéticas e epigenéticas descritas na literatura como estando associadas ao CCEL, assim como alterações associadas ao desenvolvimento tumoral. Foram ainda identificadas alterações que ainda não foram reportadas como estando associadas ao cancro. Desta forma, este estudo piloto permitiu dar início ao estudo de potenciais biomarcadores associados ao CCEL. Porém, novos estudos devem ser realizados, com um número de amostras superior, de forma a identificar alterações genéticas significativas no desenvolvimento e progressão do CCEL e associa-las às características clinico patológicas dos doentes.
APA, Harvard, Vancouver, ISO, and other styles
19

Dias, Alexandre Torchio. "Investigação citogenômica tecidual post-mortem em portadores de malformações congênitas." Universidade de São Paulo, 2015. http://www.teses.usp.br/teses/disponiveis/5/5144/tde-06012016-111509/.

Full text
Abstract:
Introdução: As malformações congênitas (MCs) são a segunda causa de mortes fetais e infantis no Brasil e, em grande parte dos casos, a sua etiologia não é bem definida. Devido às consequências clínicas das MCs, alguns pacientes falecem sem tempo hábil para uma investigação etiológica acurada. Dessa forma, a maioria dos casos permanece sem uma confirmação molecular das suspeitas clínicas, dificultando o aconselhamento genético para as famílias. Objetivos: O presente trabalho utilizou técnicas citogenômicas para caracterizar molecularmente a presença de anormalidades no DNA, desde aneuploidias até a variação do número de cópias gênicas (CNVs) em diferentes tecidos de pacientes falecidos portadores de MC encaminhados ao Serviço de Verificação de Óbitos para avaliação anatomopatológica. Casuística e Métodos: Foram avaliadas amostras de 30 pacientes portadores de MC submetidos à necropsia. O DNA foi extraido de diferentes tecidos (cérebro, coração, fígado, pele e diafragma) previamente conservados em RNA later, formol ou emblocados em parafina. Foram utilizadas as técnicas de Multiplex Ligation-dependent Probe Amplification (MLPA) com os kits P095, P064 e P070 (MRC-Holland®), Marcadores Microssatélites (MMS) com o kit MiniFiler (Life Technologies®), a Fluorescence in Situ Hybridization (FISH), a técnica de array (Infinium® CytoSNP-850K BeadChip - Illumina) e o Sequenciamento Bidirecional por Sanger. A interpretação dos resultados foi realizada utilizando os softwares GeneMarker, Coffalyser, BlueFuse Multi, Sequencher e com os bancos de dados Database of Genomic Variants (DGV - http://projects.tcag.ca/variation/), Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources (DECIPHER - http://decipher.sanger.ac.uk/), UCSC Genome Bioinformatics (http://genome.ucsc.edu) e Mutation Taster. Resultados: Dos 30 pacientes avaliados, 13 apresentaram alterações patogênicas. Entre eles, oito apresentaram aneuploidias envolvendo os cromossomos 13, 18, 21, X e Y, sendo dois deles com mosaicismo intratecidual. Quatro pacientes apresentaram microdeleções ou microduplicações envolvendo diferentes genes, sendo um paciente com duplicação do gene TYMS em 18p11.32; um com deleção do gene CHL1 em 3p26.3; um com deleção para o gene HIC1 em 17p13.3 e um paciente com deleção do gene TOM1L2 em 17p11.2; um paciente apresentou mutação de base única, patogênica, g.8535C > G (c.746C > G) no éxon 7 do gene FGFR3 compatível com Displasia Tanatofórica tipo I. Por fim, dois pacientes com doenças do desenvolvimento sexual apresentaram resultados dos testes citogenômicos normais. Discussão: Sugere-se que todas as alterações encontradas estão relacionadas ao fenótipo clínico ou participam na via de sinalização de genes correlatos. As técnicas de MLPA e MMS mostraram viabilidade e eficiência para a detecção de alterações genômicas em tecidos de pacientes falecidos, contudo são dependentes da integridade e quantidade do DNA obtido. Conclusão: O estudo citogenômico post-mortem é importante para a elucidação diagnóstica de casos sem etiologia definida, para o aconselhamento genético familiar, para a caracterização de mosaicismo inter e intratecidual e para a compreensão da patogênese das MCs
Introduction: Congenital malformations (CMs) are the second leading cause of fetal and infant deaths in Brazil and in most cases the etiology is not well defined. Also, the patients remain without a conclusive diagnostic making difficult the genetic counseling. Objectives: This study applied cytogenomics techniques in order to characterize the presence of DNA abnormalities, as well as, aneuploidies and genomic copy number variations (CNVs) in different tissues from deceased patients with CM from \"Serviço de Verificação de Óbitos\". Patients and Methods: We evaluated samples from 30 patients undergoing necropsy. The DNA was extracted from different tissues (brain, heart, liver, skin and diaphragm) stored in RNA later, formaldehyde and embedded in paraffin. We performed Multiplex Ligation-dependent Probe Amplification (MLPA) with P095 kits, P064 and P070 (MRC-Holland®), microsatellite markers (MMS) with MiniFiler kit (Life Technologies), Fluorescence In Situ Hybridization (FISH), array technique (Infinium® CytoSNP-850K BeadChip - Illumina) and bidirectional sequencing by Sanger. The results was analyzed using different softwares: GeneMarker, Coffalyser, BlueFuse Multi Sequencher and databases Database of Genomic Variants (DGV - http://projects.tcag.ca/variation/) Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources (Decipher - http://decipher.sanger.ac.uk/), UCSC Genome Bioinformatics (http://genome.ucsc.edu) and Mutation Taster. Results: The results showed 13 patients with pathogenic CNVs, and among them, eight presented aneuploidies involving chromosomes 13, 18, 21, X and Y. Two of them presented intra-tissue mosaicism. Also four patients showed several different microdeletions or microduplications: duplication of TYMS gene (18p11.32); deletion of CHL1 gene (3p26.3); deletion of HIC1 gene (17p13.3); deletion of TOM1L2 gene (17p11.2 ). One patient showed a pathogenic missense mutation of g.8535C>G (c.746C > G) in exon 7 from FGFR3 gene compatible with Thanatophoric Dysplasia type I. And two patients presented sexual development disorders and normal molecular results. Discussion: We conclude that the genomic abnormalities found in different tissues are pathogenic and associated to clinic manifestations in all patients studied. Besides, the cytogenomic techniques applied were efficient to help in the conclusive diagnostic; however, there are dependent of integrity and quality of DNA. Conclusion: Indeed the post-mortem cytogenomic study is crucial to genetic counseling, to characterize the presence of intra-tissue mosaicism and also to better understand the pathogenesis of congenital malformations
APA, Harvard, Vancouver, ISO, and other styles
20

Franchim, Camila Sommerauer. "Detecção de microdeleções do cromossomo Y em pacientes inférteis, comparando os resultados obtidos pelas técnicas de PCR e MLPA." Universidade de São Paulo, 2018. http://www.teses.usp.br/teses/disponiveis/5/5139/tde-05122018-123305/.

Full text
Abstract:
INTRODUÇÃO: O cromossomo Y contém genes primordiais para o desenvolvimento testicular e a espermatogênese. Sua conformação repetitiva predispõe à ocorrência de deleções e duplicações, que tem impacto clínico. As microdeleções nas regiões AZF afetam loci responsáveis pela espermatogênese e são uma das causas mais frequentes de azoospermia e oligozoospermia. Seu diagnóstico tem valor preditivo para o sucesso na recuperação cirúrgica de espermatozoides testiculares em homens azoospérmicos. A técnica utilizada para detectá-las é a reação de polimerização em cadeia (PCR), porém os protocolos divergem entre si, havendo muita variabilidade na incidência destas deleções. À vista disso, sugerimos utilizar a técnica de Amplificação de Múltiplas Sondas dependente de Ligação (MLPA). OBJETIVO: Comparar os resultados obtidos com as técnicas de PCR e MLPA na detecção de microdeleções do cromossomo Y em homens inférteis. RESULTADOS: Analisamos 43 pacientes inférteis (azoospérmicos e oligozoospérmicos) e 40 homens férteis (controle) pelas técnicas de PCR e MLPA. Encontramos 7 deleções por PCR (16,2%) e 9 por MLPA (21%), além de 5 duplicações e um mosaico. DISCUSSÂO: Além das deleções, as duplicações também podem gerar instabilidades nos genes do cromossomo, podendo levar a infertilidade. CONCLUSÕES: Os resultados obtidos por ambas as técnicas revela que a MLPA é uma técnica mais sensível que a técnica de PCR para detectar microdeleções do cromossomo Y
INTRODUCTION: The Y chromosome contains several genes responsible for testicular development and spermatogenesis. Its repetitive conformation predisposes this chromosome to deletions and duplications that have clinical impact. Microdeletions in the AZF regions affect loci responsible for spermatogenesis and are one of the most frequent causes of azoospermia and oligozoospermia. This diagnosis may have a predictive value for success in the surgical recovery of testicular spermatozoa in azoospermic men. The gold standard method for this detection is polymerase chain reaction (PCR), but protocols diverge among them, generating a great variability in the incidence of these deletions. PURPOSE: We evaluated another molecular diagnostic method, Multiplex Ligand Probe Dependent Amplification (MLPA), which generates more genomic data (such as duplications and rearrangements) in a single reaction, leading to a better understanding of these patients phenotype. OBJECTIVE: To compare the results obtained with PCR and MLPA techniques in the detection of Y chromosome microdeletions in infertile men. RESULTS: We analyzed 43 infertile patients (azoospermic and oligozoospermic) and 40 fertile men (control) by PCR and MLPA techniques. We found 7 deletions by PCR (16.2%) and 9 by MLPA (21%), in addition to 5 duplications and one mosaic. DISCUSSION: Besides deletions, duplications can also generate instability in the chromosome genes, which may lead to infertility, and it is important being capable to diagnose these alterations with a faster and more effectively method. CONCLUSIONS: The results obtained by both techniques reveal that MLPA is more sensitive than PCR to detect microdeletions of the Y chromosome
APA, Harvard, Vancouver, ISO, and other styles
21

Villela, Darine Christina Maia. "Alterações genômicas e epigenômicas nas manifestações anatomopatológicas e cognitivas da doença de Alzheimer." Universidade de São Paulo, 2014. http://www.teses.usp.br/teses/disponiveis/41/41131/tde-16012015-143817/.

Full text
Abstract:
A doença de Alzheimer (DA) é a causa mais comum de demência na população, sendo responsável por cerca de 50 a 60% dos casos. Embora o diagnóstico clínico da doença na maioria das vezes seja acurado, a confirmação da DA só é feita post mortem através principalmente da caracterização dos dois tipos principais de lesões neurais: depósitos extracelulares de placas de β amiloide e emaranhados de proteína tau hiperfosforilada. Até o momento, o envolvimento de apenas quatro genes foi confirmado na etiologia da DA, três deles (APP, PSEN1 e PSEN2) associados à forma familial de herança mendeliana, que corresponde a um tipo raro e grave. No entanto, apesar de inúmeros trabalhos de associação genômica, (Genome wide association studies- GWAS) sugerirem uma possível participação de vários outros genes na suscetibilidade à manifestação da forma multifatorial da DA, o gene APOE, ainda é o único consistente e reproduzivelmente associado à doença. As descobertas derivadas dos GWAS investigando o papel de SNPs coletivamente explicam somente uma pequena porcentagem da variação herdada que contribui para o risco de desenvolver a DA. Atualmente, há novas abordagens para investigar a base genética do restante da variabilidade fenotípica herdada e que pode influenciar a suscetibilidade ao desenvolvimento de doenças complexas. O papel da variação do número de cópias de segmentos de DNA (Copy Number Variation - CNV) na genética de doenças complexas foi demonstrado por diversos estudos nos últimos anos e evidencia que desequilíbrios genômicos também podem contribuir significantemente para a resistência ou susceptibilidade a várias patologias. Outro aspecto que vem assumindo crescente importância é a análise de modificações epigenéticas que podem constituir um mecanismo molecular básico e contribuir diretamente para a patogênese da DA. Logo, este trabalho teve como objetivo principal investigar dois aspectos relacionados à DA: (1) a identificação de CNVs que podem estar contribuindo para o desenvolvimento da forma multifatorial da DA, usando a técnica de array-CGH, e (2) a análise de alterações do padrão global de metilação do DNA no córtex frontal de indivíduos com a forma multifatorial da DA, usando um microarranjo que interroga o status de metilação de 450.000 sítios CpGs. Em nossa investigação sobre desequilíbrios genômicos na DA, identificamos 6 CNVs raras com conteúdo gênico relevante para o fenótipo investigado. Dois indivíduos distintos do grupo DA apresentam microduplicações em genes que codificam diferentes subunidades do mesmo tipo de canal de Ca2+ dependente de voltagem, o tipo L. Além disso, dos outros genes selecionados como especialmente interessantes, 4 estão envolvidos em diferentes processos inflamatórios e 1 é responsável por codificar a enzima nicotinamida fosforibosiltransferase, participante importante da via de biossíntese da molécula nicotinamida adenina dinucleotídeo (NAD). A implicação de um possível envolvimento de mediadores da sinalização celular do Ca2+ e da via de biossíntese da NAD na etiologia da DA também foi reforçada pelos nossos resultados sobre o padrão de metilação do DNA na DA. Dois genes importantes para a homeostasia intracelular do Ca2+ e via de biossíntese da NAD apresentaram sítios CpGs diferenciamente metilados nos sujeitos com DA
Alzheimer\'s disease (AD) is the most common form of dementia in the population, corresponding to 50-60% of all cases. Although clinical diagnosis seems to be accurate, the definitive diagnosis of the disease can only be made by a post mortem neuropathological exam that certifies the presence of the two hallmarks of AD: the accumulation of extracellular senile plaques containing β-amyloid (Aβ) and the intracellular neurofibrillary tangles containing hyperphosphorylated tau protein. Four genes are known to be involved in the etiology of AD, three of them (APP, PSEN1 and PSEN2) are associated to the familial form of the disease, which show autosomal dominant inheritance and correspond to the more severe and rare type of AD. Despite many genome wide association studies (GWAS), APOE still remains the only unequivocal genetic risk factor associated to the multifactorial form of AD. The discoveries from GWAS using SNPs collectively explain only a small percentage of heritable variation that may contribute in AD risk. Currently, new approaches have been used to investigate the genetic basis of the phenotypical variability inheritance that can influence the susceptibility of complex diseases. The important role of DNA copy number variation (CNV) has been demonstrated by several studies over the last years and shows that genomic imbalances may also significantly contribute to resistance or susceptibility to various complex diseases. Additionally, there is now increasing interest in exploring how epigenetic modifications, in particular DNA methylation, could influence complex diseases etiology. Thus, the major aim of this work were to investigate two aspects related to the multifactorial form of AD: (1) identification of rare CNVs, using array-CGH, that could contribute to the development of the disease, and (2) analysis of the DNA methylation pattern in frontal cortex of individuals with AD. In our study, we identified 6 rare CNVs with relevant gene content to the investigated phenotype. Two distinct subjects with AD from our casuistic presented microduplications in genes that encode different subunits of the same type of Ca2+ voltage channel, the L-type. Furthermore, among the other selected genes, four are involved in different inflammatory process and one encodes the nicotinamide phosphoribosyltransferase enzyme, important mediator of nicotinamide adenine dinucleotide (NAD) biosynthesis. The implication of a possible involvement of Ca2+ intracellular signaling mediators and NAD biosynthesis pathway in the etiology of AD was also reinforced by our analysis of DNA methylation pattern. Interestingly, two important genes, one to intracellular Ca2+ homeostasis and the other to NAD biosynthesis pathway presented CpGs sites differently methylated in the AD subjects
APA, Harvard, Vancouver, ISO, and other styles
22

Gonçalves, Andressa Pereira. "Mutações no gene JARID1C e rearranjos subteloméricos como causas de deficiência intelectual familiar de etiologia idiopática." Universidade do Estado do Rio de Janeiro, 2012. http://www.bdtd.uerj.br/tde_busca/arquivo.php?codArquivo=5677.

Full text
Abstract:
Fundação Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro
A Deficiência Intelectual (DI) é uma condição complexa, que acomete 2-3% da população mundial, constituindo um importante problema de saúde pública. No entanto, uma parcela significativa dos casos de DI permanece sem um diagnóstico definitivo, o que demonstra que muitos fatores etiológicos associados a esta condição ainda precisam ser elucidados. Há um consenso de que o número de homens com DI supera em 30% o número de mulheres, um achado atribuído à presença de mutações em genes localizados no cromossomo X. Dentre os genes presentes neste cromossomo que são expressos no cérebro, o Jumonji AT-rich interactive domain 1C (JARID1C) foi identificado como um potencial candidato a estar relacionado à DI ligada ao X (DILX). O gene JARID1C codifica uma desmetilase da lisina 4 da histona H3 (H3K4), imprescindível para a regulação epigenética. Tão importante quanto o estudo do gene JARID1C em pacientes com DI é a busca por variações no número de cópias gênicas (VNCs) em regiões cromossômicas subteloméricas. Genes relacionados ao desenvolvimento cerebral são enriquecidos em VNCs e as regiões subteloméricas são mais susceptíveis à formação destes rearranjos. Diante do exposto, neste estudo, investigamos mutações no gene JARID1C (exons 3, 4, 5, 8, 10, 14 e 23) em 148 homens portadores de DI pertencentes a famílias com padrão de segregação sugestivo de DILX. Paralelamente, analisamos VNCs subteloméricas em 174 homens com DI familiar de etiologia idiopática, independente do padrão de segregação. Para todos os indivíduos selecionados, amostras de DNA genômico foram extraídas a partir de sangue periférico e alterações genéticas frequentemente relacionadas à DI foram previamente excluídas (expansões trinucleotídicas nos loci FRAXA e FRAXE e mutações nos genes MECP2 e ARX). A análise do gene JARID1C foi realizada pela técnica de PCR, seguida da análise dos produtos amplificados por sequenciamento. Foram identificadas quatro variantes silenciosas (c.564G>A, c.633G>C, c.1884G>A, c.1902C>A). Através da análise in silico de sequências exônicas acentuadoras de splicing (ESEs) localizadas nas posições das variantes encontradas, foi possível classificar a variante c.1884G>A como neutra e as três variantes restantes como possíveis criadoras de ESEs. Já para a investigação das VNCs subteloméricas, foi utilizada a metodologia de Multiplex Ligation-dependent Probe Amplification (MLPA), capaz de identificar microdeleções e microduplicações nas 46 regiões subteloméricas. Para este fim, inicialmente, os indivíduos foram investigados pelo kit de MLPA P036, enquanto que para aqueles que exibiram alterações também foi utilizado o kit P070. A validação das VNCs encontradas foi realizada por PCR quantitativo em Tempo Real. A análise por MLPA revelou um indivíduo apresentando duas deleções (9p e 13q), um indivíduo apresentando duas amplificações (1p e 2p), dois indivíduos apresentando uma deleção e uma amplificação (18p e 18q; 4p e 8p), quatro indivíduos portadores de uma deleção cada (10p, 20p, 3q e 22q) e dois indivíduos com uma amplificação cada (7q e 20p). Algumas das alterações subteloméricas encontradas (2,87%) representam VNCs de relevância clínica para o estudo da DI, reforçando a importância do rastreamento de rotina de VNCs subteloméricas na DI familiar. Consideramos que a elucidação de novos genes ou mecanismos moleculares diretamente relacionados à DI é um caminho promissor e urgente para o estabelecimento de novas estratégias terapêuticas possíveis.
Intellectual Disability (ID) is a complex condition, which affects 2-3% of general population, constituting a major public health problem. Nevertheless, a significant number of ID cases remain to have a definitive diagnosis, showing that many etiologic factors associated with this condition need to be elucidated. There is a consensus that the number of ID males exceeds by 30% the number of females, a finding that is attributed to the presence of mutations in genes located on chromosome X. Among the X-linked brain-expressed genes, the Jumonji AT-rich interactive domain 1C (JARID1C) was identified as a potential candidate to be related to X-Linked ID (XLID). The JARID1C gene encodes a histone demethylase specific for histone 3 lysine 4 (H3K4), which is indispensable for the epigenetic regulation. As important as the study of JARID1C gene in ID patients is the search for subtelomeric copy number variations (CNVs). Genes related to brain development are enriched in CNVs and subtelomeric regions are particularly susceptible to these rearrangements. In view of this evidence, in this study we investigated JARID1C mutations (exons 3, 4, 5, 8, 10, 14 and 23) among 148 males with ID from families with a segregation pattern suggestive of XLID. In parallel, we analyzed subtelomeric CNVs among 174 males with idiopathic familial ID, regardless of the segregation pattern. For all selected individuals, genomic DNA was extracted from peripheral blood and other frequent genetic causes related to ID were previously excluded (trinucleotide expansions at FRAXA and FRAXE loci and mutations in MECP2 and ARX genes). The JARID1C gene analysis was performed by PCR followed by sequencing analysis of the amplified products. We identified four silent mutations (c.564G>A, c.633G>C, c.1884G>A and c.1902C>A). In silico analysis of exonic splicing enhancers (ESEs) located in the variants positions made possible to classify the variant c.1884G>A as neutral and the remaining variants as potential creators of new ESEs. For the investigation of subtelomeric CNVs, Multiplex Ligation-dependent Probe Amplification (MLPA) methodology was applied to identify microdeletions and microduplications in the 46 subtelomeric regions. For this purpose, individuals were initially investigated by P036 MLPA kit, whereas for those who exhibited abnormalities, the P070 kit was also used. The CNVs validation was performed by quantitative Real Time PCR. The MLPA analysis revealed an individual with two deletions (9p and 13q), an individual with two amplifications (1p and 2p), two individuals with a deletion and amplification (18q and 18p; 4p and 8p), four individuals with a deletion (10p, 20p, 3q and 22q) and two individuals with an amplification (7q and 20p). Some of the changes found (2,87%) represent subtelomeric CNVs of clinical relevance for the study of ID, reinforcing the importance of routine screening of subtelomeric CVNs in cases of familial ID. We believe that the elucidation of novel genes or molecular mechanisms directly related to ID is a promising and urgent way for establishing new possible therapeutic strategies.
APA, Harvard, Vancouver, ISO, and other styles
23

Dutra, Roberta Lelis. "Investigação da variação no número de cópias genômicas (CNVs) em pacientes com anomalias congênitas e atraso de desenvolvimento neuropsicomotor (ADNPM) pela técnica de MLPA (Multiplex Ligation-dependent Probe Amplification)." Universidade de São Paulo, 2014. http://www.teses.usp.br/teses/disponiveis/5/5141/tde-25112014-120744/.

Full text
Abstract:
INTRODUÇÃO: Os desequilíbrios genômicos constituem causa frequente de abortamento, anomalias congênitas (AC) e atraso de desenvolvimento neuropsicomotor (ADNPM). O aprimoramento de novas técnicas de diagnóstico citogenômico, como por exemplo, a MLPA (Multiplex Ligation-dependent Probe Amplification) e a triagem ampla do DNA utilizando arrays, mostraram que a alteração no número normal de cópias genômicas (CNVs) influencia na patogenicidade dos fenótipos em diversas síndromes. OBJETIVOS: Com isso, os objetivos do presente estudo foram identificar CNVs em pacientes com MC e ADNPM utilizando a técnica de MLPA e, a partir dos resultados alterados, aplicar da técnica de array para a identificação de possíveis rearranjos complexos, além de associar as alterações moleculares encontradas com o fenótipo dos pacientes. MÉTODOS: Participaram do estudo 416 pacientes com MC e ADNPM. As amostras de DNA foram analisadas utilizando a técnica de MLPA com kits comerciais para as principais síndromes de microdeleções (P064) e regiões subteloméricas (P036 e P070). Dois kits de MLPA específicos para as regiões 7q11.23 (P029) e 22q11.2 (P250) também foram utilizados para complementar a identificação de CNVs atípicas. Entre os casos que apresentavam alterações pela técnica de MLPA, 15 pacientes foram submetidos à técnica de array, utilizando três diferentes plataformas: Agilent SurePrint G3 Genoma Humano microarray 180 K, HumanCytoSNP-12 BeadChip, CytoScan(TM) HD array 6.0 Affymetrix®. RESULTADOS: A análise molecular pela técnica de MLPA possibilitou a detecção de microdeleções e/ou microduplicações em 97 pacientes sendo que: em 46 pacientes foi possível encontrar alterações utilizando apenas o kit P064 (microdeleções), em 34 pacientes utilizando apenas os kits P036 e P070 (regiões subteloméricas) e em quatro pacientes só foi possível identificar a alteração utilizando outro kit de MLPA (P250), específico para alterações genômicas em 22q11.2. Rearranjos complexos, envolvendo mais de três cromossomos, foram observados em 10 pacientes. DISCUSSÃO: A MLPA permitiu detectar CNVs em 97/416 pacientes (23,3%), sendo uma técnica ideal para ser aplicada em pacientes com sinais fenotípicos inespecíficos. Algumas alterações genômicas encontradas estão relacionadas também com alterações específicas, como a presença de malformação cardíaca ou convulsões. E em outros casos a alta variabilidade fenotípica pode ser associada a um conjunto de CNVs consideradas patogênicas. Além disso, a inclusão de outra técnica de triagem, com maior cobertura do genoma permitiu detectar rearranjos complexos antes não observados mesmo em síndromes bem descritas como as síndromes de midrodeleções 7q11.23 e 22q11.2. CONCLUSÃO: A MLPA com kits combinados, por possuir maior abrangência de regiões detectadas e menor custo, é uma ferramenta valiosa para ser utilizada como um teste de triagem diagnóstica
INTRODUCTION: Genomic imbalances are the most common cause of miscarriage, congenital anomalies (CA) and mental retardation (MR). With the improvement of new cytogenomics diagnostic techniques, such as the MLPA (Multiplex Ligation-dependent Probe Amplification) and the array techniques, it have been shown that changes in the normal gene copy number influence the pathogenic variability of phenotypes in different syndromes. AIMS: The aims of the present study were to identify CNVs in patients with CM and RM using the MLPA technique and, from the abnormalities results, to apply the array methodology for the identification of complex rearrangements. Furthermore, the study aimed to associate the alterations found by molecular techniques with the phenotype of patients. METHODS: 416 patients with CM and RM participated in the study. The samples were analysed by MLPA technique with commercial kits for the main microdeletion syndromes (P064) and subtelomeric regions (P036 and P070). Two more MLPA kits for specific regions 7q11.23 (P029) and 22q11.2 (P250) were used to confirm the altered results and to complement some results with the identification of atypical abnormalities. From the patients who presented abnormalities by MLPA technique, 15 underwent by microarray-based comparative genomic hybridization (CGH-array) technique, using three different platform: Agilent SurePrint G3 Human Genome microarray 180 kb, HumanCytoSNP -12 BeadChip, CytoScan(TM) HD ® and Affymetrix 6.0. RESULTS: The molecular analysis by MLPA technique allowed the detection of microdeletions and/or microduplications in 97 patients. In 46 patients it was possible to find genomic alteration using only MLPA kit P064 and in 34 patients using only the subtelomeric kits P036 and P070. For four patients it was only possible to identify the genomic abnormalities using another specific MLPA kit (P250), involving the 22q11.2 region. Complex rearrangements involving more than three chromosomes were detected in 10 patients. DISCUSSION: The MLPA technique was capable of detecting CNVs in 97/416 (23,3%) of patients, being an ideal technique to be applied in patients with non-specific signs phenotypic. Some genomic alterations found are, also related to specific changes, such as the presence of cardiac malformation or convulsions. In other cases, the high phenotypic variability may be associated to certain group of pathogenic CNVs. Moreover, the inclusion of additional screening method, with greater coverage, allowed the detection of complex rearrangements not seen before even in syndromes as well described microdeletions syndromes on 7q11.23 and 22q11.2 regions. CONCLUSION: The MLPA technique can be a valuable tool used as a molecular screening test, because it has greater coverage and lower cost of detected regions
APA, Harvard, Vancouver, ISO, and other styles
24

Barbosa, Fernanda Bueno. "Perfil de variação no número de cópias do DNA e regiões de perda de heterozigose na susceptibilidade ao lúpus eritematoso sistêmico." Universidade de São Paulo, 2017. http://www.teses.usp.br/teses/disponiveis/17/17135/tde-10042018-155016/.

Full text
Abstract:
O lúpus eritematoso sistêmico (LES) é uma doença autoimune com forte componente genético, caracterizada por inflamação crônica e produção de autoanticorpos. O objetivo deste trabalho foi determinar o perfil de variação no número de cópias (CNVs) e de regiões de perda de heterozigose (LOH) na patogênese do LES. A detecção de CNVs e LOH foi feita pela metodologia Cytoscan HD array em pacientes com LES (n = 23) e indivíduos saudáveis (n = 110). Devido à formação tri-híbrida da população brasileira, foi desenvolvido e validado um painel de 345 marcadores informativos de ancestralidade, a partir dados provenientes do próprio array, para estimar as proporções de ancestralidade individual e, em última instância, inseri-las nos modelos de regressão logística como variável de controle nas análises de distribuição de CNVs e LOH. O perfil de CNVs evidenciou que o número e o tamanho de duplicações são maiores nos indivíduos saudáveis do que nos pacientes com LES. Duplicações nos genes FCGR3B e ADAM3A foram descritas como fator de proteção ao LES, quando tais genes foram avaliados por PCR quantitativa em maior grupo amostral de pacientes (n = 135) e controles (n = 200). Além disso, mostrou-se o efeito sinérgico da presença da deleção em ambos os loci FCGR3B e ADAM3A no aumento do risco para desenvolver a doença. Deleções em pacientes com LES envolvendo os genes CFHR4, CFHR5 e HLA-DPB2, previamente descritos em associação com o LES na literatura, foram identificadas por array e confirmadas por PCR digital. O protocolo desenvolvido para identificação de variantes raras, resultou em um conjunto de 21 CNVs raras em pacientes com LES. Em relação às regiões de perda de heterozigose, não foram encontradas evidências de que o número médio e a extensão dos segmentos LOH seja diferente entre pacientes e indivíduos saudáveis. No entanto, os cromossomos 6 e 12 em pacientes exibem regiões de perda de heterozigose em maior quantidade e tamanho do que os de indivíduos saudáveis, além de apresentarem 17 segmentos LOH restritos ao grupo de pacientes com LES. Os resultados aqui descritos evidenciam que novos loci de susceptibilidade ao LES podem ser encontrados quando a distribuição de CNVs é analisada em todo o genoma, em que a investigação de sua relação com a patogênese pode contribuir para a compreensão da base genética da doença.
Systemic lupus erythematosus (SLE) is an autoimmune disease with a strong genetic background characterized by chronic inflammation and autoantibody production. The purpose of this study was to determine the copy number variation (CNV) and loss of heterozygosity (LOH) profiles in the susceptibility to SLE. The detection of CNVs and LOH was performed by the Cytoscan HD array methodology in SLE patients (n = 23) and healthy subjects (n = 110). Due to the tri-hybrid composition of the Brazilian population, a panel of 345 ancestral informative markers was developed and validated, based on data from the array itself, to estimate the proportions of individual ancestry and, ultimately, to insert them into the logistic regression models as a control variable in the analysis of CNV and LOH distribution. The CNVs profile showed that the burden and the size of duplications are higher in healthy individuals than in SLE patients. Duplications in FCGR3B and ADAM3A genes were described as a protective factor for SLE, when these genes were evaluated by quantitative PCR in a larger SLE (n = 135) and control (n = 200) groups. In addition, the synergistic effect of the presence of deletion in both FCGR3B and ADAM3A loci increase the risk of developing the disease. Deletions in SLE patients encompassing the CFHR4, CFHR5 and HLA-DPB2 genes, previously described in the literature in association to SLE, were identified by the array and confirmed by droplet digital PCR. The pipeline developed here for the identification of rare variants resulted in a set of 21 rare CNVs in SLE patients. Regarding the loss of heterozygosity regions, no evidence was found that the mean number and extent of LOH segments is different between patients and healthy individuals. However, the chromosomes 6 and 12 in SLE patients exhibit greater quantity and size of LOH than those of healthy individuals, besides showing 17 LOH segments restricted to the group of SLE. The results described here show that novel susceptibility loci to SLE can be found once the distribution of variants is analyzed throughout the genome, in which the investigation of its relation to the pathogenesis may contribute to the understanding of the genetic basis of the disease.
APA, Harvard, Vancouver, ISO, and other styles
25

Piazzon, Flavia Balbo. "Investigação clínica e citogenética molecular em pacientes com atraso de desenvolvimento neuropsicomotor associado à malformação congênita." Universidade de São Paulo, 2016. http://www.teses.usp.br/teses/disponiveis/5/5144/tde-24032016-145538/.

Full text
Abstract:
Introdução: Com a sofisticação das técnicas de análise do DNA, a medicina moderna tem à sua disposição boas possibilidades para elucidar quadros clínicos indefinidos em pacientes que possuem microrrearranjos cromossômicos complexos. O desenvolvimento da técnica de MLPA (Multiplex ligation-dependent probe amplification) aliado à tecnologia dos arrays (WGAS - whole genome array screening) possibilitou analisar de uma só vez, diferentes regiões de interesse clínico no genoma humano. Objetivo: O presente trabalho teve como objetivo estudar pacientes com atraso de desenvolvimento neuropsicomotor (ADNPM) associado à malformação congênita (MC) com cariótipo prévio normal ou inconclusivo. Material e métodos: Participaram do estudo 71 pacientes com ADNPM associado à MC que foram analisados utilizando o teste de MLPA com os kits P036 e P064, seguido de WGAS com as diferentes plataformas (Agilent, Affymetrix e Illumina). Resultados: Entre os 33 pacientes com alterações patogênicas e de significado clínico incerto (VOUS) encontramos: 12 pacientes com deleção, 5 com duplicação e 16 com duplicações e deleções (dup/del) concomitantes. Foram 29 pacientes com alterações patogênicas conclusivas, 4 pacientes com CNVs classificadas como VOUS e 15 pacientes tiveram resultado de array normal além dos outros 23 que apresentaram alterações benignas, ou por não apresentarem genes na região alterada, ou por serem genes sem fenótipos descritos, ou ainda, as alterações foram herdadas de genitores normais. Na casuística total foram encontrados 4 pacientes com regiões de perda de heterozigosidade. Conclusões: A utilização de uma estratégia combinada utilizando diferentes kits de MLPA, com capacidade para detectar as principais microalterações genômicas patogênicas conhecidas, associada à aplicação do WGAS possibilitou a detecção de alterações submicroscópicas, bem como a correlação clínica adequada para pacientes não diagnosticados pela citogenética clássica. Dessa forma, nosso estudo sugere um novo modelo para a aplicação combinada desses testes que representa uma alternativa de bom custo-benefício para a triagem genômica e definição diagnóstica dos pacientes com quadros sindrômicos complexos e suas famílias
Introduction: The recent technological advances on DNA-based techniques have established in modern medicine good opportunities to elucidate undefined clinical cases in patients with complex chromosomal microrearrangements. The performance of MLPA (Multiplex ligation-dependent probe amplification) technique together with array technologies (WGAS - whole genome array screening) created the possibility of one single experiment to analyze different regions of interest in the human genome. Objective: Patients with psychomotor delay (PSMD) associated with multiple congenital anomalies who had normal or inconclusive G-band-karyotype (MCA) were studied in order to understand the genotype-phenotype correlations. Material and methods: This study involved 71 patients with psychomotor delay (PSMD) associated with multiple congenital anomalies (MCA) analyzed by MLPA (P036 and P064 kits), followed by WGAS different platforms (Agilent, Affymetrix e Illumina®). Results: Among 33 patients with pathogenic and uncertain (VOUS) copy number variations (CNV) were found: 12 deletions, 5 duplications and 16 concomitant duplication and deletion (dup/del). There were 29 patients with conclusive pathogenic findings, 4 patients with VOUS and 16 patients with normal array, but others 23 patients with benign results, which means there is no gene content in the region involved, or because these genes were not linked to phenotype, or even due to CNVs inherited of healthy parents. From the whole casuistic, 4 individuals presented loss of heterozygosity (LOH) regions. Conclusions: The use of a combined strategy of analysis (MLPA - WGAS) with a high capacity to detect pathogenic CNVs allows unraveling microscopic imbalances, and consequently, offers an adequate clinical correlation for patients not previously diagnosed by classical cytogenetics. In conclusion, this study suggests a new model for the combined application of these techniques, which represents an optimal alternative for a genomic screening and diagnostic establishment in patients with rare complex disorders and their families
APA, Harvard, Vancouver, ISO, and other styles
26

Hansson, Caisa Marie. "Analysis of Genetic Alterations in Patients Affected with Neurofibromatosis Type 2 and its Associated Tumors." Doctoral thesis, Uppsala : Acta Universitatis Upsaliensis : Univ.-bibl. [distributör], 2006. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-6511.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

Brennan, Rebecca Ruth. "Genetic factors modulating mitochondrial DNA copy number." Thesis, University of Newcastle upon Tyne, 2017. http://hdl.handle.net/10443/3960.

Full text
Abstract:
Mitochondria are dynamic organelles whose principal role is the generation of cellular energy (ATP) through oxidative phosphorylation (OXPHOS). 13 OXPHOS subunits are encoded by the mitochondrion’s polyploid circular genome (mtDNA), and the nuclear genome (nDNA) encodes the remaining subunits as well as proteins required for mtDNA maintenance. In addition to mitochondrial number, mtDNA copy number (mtDNA CN) varies between cell and tissue type, depending on metabolic demand and baseline mtDNA quality, and ranges from hundreds to thousands of copies per cell. mtDNA CN is often linked to mitochondrial dysfunction and the ubiquity of mitochondria results in a broad spectrum of dysfunction and clinical phenotypes; ranging from primary mitochondrial disorders to complex diseases such as cancer, type 2 diabetes, and Parkinson’s disease. Given the variability in mtDNA between individuals, it is possible that mtDNA CN is influenced by secondary factors. I hypothesise that nDNA diversity is a major component of mtDNA variability between individuals and will test this hypothesis by conducting a genome wide association study (GWAS) in a large, European, asymptomatic cohort (>8000 individuals), comparing nDNA genotype to mtDNA copy-number as a QTL. Peripheral blood mtDNA CN was correlated to array-based and imputed nDNA genotype in a two-stage QTL analysis, utilising three independent replicative cohorts: UKBS, Newcastle, and ALPAC. In addition the effect of potential confounding biological variables such as age, gender, blood count, and potential methodological confounders such as assay variation, technical and biological replicate numbers, and differences in genotype platform were all assessed and used to improve the GWAS analysis. Individual cohort analysis identified nuclear gene UNC13C (Unc-13 Homolog C), two intergenic, and one intronic SNP, which is in close proximity to PSMD3 (Proteasome 26S Subunit, Non-ATPase 3), to be genome wide significant (GWS) (p < 1.00E-07) in individual cohort analysis. However these hits could not be replicated in meta-analysis. mtDNA variant analysis in all three cohorts revealed that mtDNA SNPs G5460A and G5046A, which identify as mitochondrial haplogroup W, were significantly associated to a significant reduction in mtDNA CN. Furthermore, our work identified gender-specific genetic differences, which was supported by a Preliminary iv significant decrease in mtDNA CN in males with age, but not females, and significant changes in mtDNA CN relative to blood cell type and proportions highlighted the importance of regulating for cellular heterogeneity. Additionally, no difference in mtDNA CN was observed between pre- and post-menopausal women. This work indicates that there are likely genetic variants present at the population level modulating mtDNA CN, but that this process is complex and multifaceted.
APA, Harvard, Vancouver, ISO, and other styles
28

Madia, Fabrícia Andréia Rosa. "Estudo da variação do número de cópias gênicas (CNVs) em amostras post-mortem de malformados cardíacos congênitos (MCCs) sindrômicos." Universidade de São Paulo, 2018. http://www.teses.usp.br/teses/disponiveis/5/5141/tde-17082018-090808/.

Full text
Abstract:
As malformações cardíacas congênitas (MCCs) são as malformações mais comuns ao nascimento, representando uma importante causa de morbidade e mortalidade em recém-nascidos. Nos últimos anos, estudos utilizando testes citogenômicos têm permitido elucidar e compreender melhor as causas das MCCs. O objetivo geral desse estudo foi investigar a presença de CNVs em amostras de tecido obtidas post-mortem de portadores de malformações cardíacas congênitas sindrômicas; e os objetivos específicos consistiram em avaliar a frequência das CNVs, destacando as mais relevantes, comparar a presença de CNVs nos diferentes tecidos e realizar a correlação genótipo-fenótipo. Para isso, foram estudados um total de 52 casos de natimortos e recém-nascidos provenientes do Serviço de Verificação de Óbitos - FMUSP. Amostras de DNA extraídas da pele, diafragma e do coração foram avaliadas utilizando o kit AmpFlSTR® MiniFiler(TM) PCR Amplification (Life Technologies(TM), USA) e a técnica de Multiplex Ligation-dependent Probe Amplification (MLPA) com diferentes kits (MCR-Holland, Holanda). A técnica de FISH foi utilizada para a confirmação dos resultados obtidos em um dos casos estudados. Foram encontradas CNVs relevantes em 21 casos, incluindo trissomia do 18 (10 casos), trissomia do 21 (4 casos), trissomia do 13 (2 casos), trissomia do 16 (1 caso), monossomia do X em mosaico (1 caso), dup 4p16 (1 caso), dup 11q25 (1 caso) e del GATA4 éxon 6 (1 caso). A análise genômica se mostrou eficiente na investigação das bases genômicas e na caracterização das diferentes malformações em amostras post-mortem de portadores de MCC sindrômicas
Congenital heart defects (CHDs) are the most common birth defect and represent an important cause of morbidity and mortality in newborns. In recent years, studies using cytogenomic tests have enabled an improved understanding of the causes of CHD. The general objective of this study was to investigate the presence of CNVs in post-mortem tissue samples from patients with congenital syndromic cardiac malformations; and the specific objectives were to evaluate the frequency of CNVs, highlighting the most relevant ones, to compare the presence of CNVs in the different tissues and to perform the genotype-phenotype correlation. For this, a total of 52 stillbirth and newborn cases from the Death Verification Service (SVO), FMUSP were investigated. DNA samples from skin, diaphragm and heart tissues were evaluated using an AmpFlSTR® MiniFiler(TM) PCR Amplification Kit (Life Technologies(TM), California, USA) and Multiplex Ligation-dependent Probe Amplification (MLPA) with different kits (MCRHolland, Amsterdam, The Netherlands). FISH was used to confirm the results of one of the studied cases. The results showed relevant copy number variations (CNVs) in 21 cases, including trisomy 18 (10 cases), trisomy 21 (4 cases), trisomy 13 (2 cases), trisomy 16 (1 case), mosaic monosomy X (1 case), dup 4p16 (1 case), dup 11q25 (1 case) and del GATA4 exon 6 (1 case). Genomic analysis was found to efficiently identify the genomic basis of, and characterize, various malformations found in postmortem samples from syndromic CHD carriers
APA, Harvard, Vancouver, ISO, and other styles
29

Kariminejad, Roxana [Verfasser]. "Copy Number Variations in Structural Brain Malformations / Roxana Kariminejad." Berlin : Freie Universität Berlin, 2012. http://d-nb.info/1030383413/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

Akrami, Seyed Mohammad. "Diagnostic application of human DNA copy number analysis." Thesis, University of Nottingham, 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.250585.

Full text
APA, Harvard, Vancouver, ISO, and other styles
31

Meng, Shasha. "Mitochondrial DNA Copy Number, Lifestyle and Cancer Risk." Thesis, Harvard University, 2015. http://nrs.harvard.edu/urn-3:HUL.InstRepos:16121153.

Full text
Abstract:
Mitochondria are membrane-bound organelles found in the cytoplasm of almost all eukaryotic cells. Their main functions include energy metabolism, free radical production, calcium homeostasis and apoptosis. Located closely to the source of reactive oxidative stress (ROS) production, Mitochondrial DNA (mtDNA) is extremely susceptible to oxidative damage due to its absence of protective histones, the lack of introns and a scarcity of the efficient DNA repair mechanisms. Associations between leukocyte mtDNA copy number (mtCN) and various oxidative stress related health outcomes have been demonstrated in multiple prospective studies. MtCN has also been suggested to be a contributor to many cancer types. These pieces of evidence suggest that mtCN in leukocytes may serve as a candidate biomarker for oxidative stress related general health outcomes. In this work, we determined associations between mtCN and skin cancer as well as lung cancer risk by case-control studies nested within the Nurses’ Health Study (NHS) and the Health Professional Follow-Up Study (HPFS). Furthermore, we examined relationships between various oxidative stress generating factors (age, smoking, physical activity, body anthropometric indices, weight change and alcohol consumption) and mtCN among women using controls from the previous two studies. Relative mtCN in peripheral blood leukocytes (PBL) was measured by quantitative PCR (qPCR)-based assay and covariates were collected by biannually updated questionnaires. Our results indicate that obesity and weight gain are associated with lower mtCN. Moreover, mtCN may be more sensitive to obesity, while telomere length reflects aging better. In terms of cancer risks, women with low mtCN are more likely to develop skin cancer and the increased melanoma risk associated with low mtCN is more apparent among women with low constitutional risk or high UV exposure history. Although mtCN was not significantly associated with lung cancer risk, current smokers might be more susceptible for the disease when mtCN first starts to decrease.
Epidemiology
APA, Harvard, Vancouver, ISO, and other styles
32

Buckley, Patrick. "Development and Application of Microarray-Based Comparative Genomic Hybridization : Analysis of Neurofibromatosis Type-2, Schwannomatosis and Related Tumors." Doctoral thesis, Uppsala : Acta Universitatis Upsaliensis : Univ.-bibl. [distributör], 2005. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-4786.

Full text
APA, Harvard, Vancouver, ISO, and other styles
33

Sahli, Atef. "Copy number variations in the gene space of Picea glauca." Doctoral thesis, Université Laval, 2017. http://hdl.handle.net/20.500.11794/36434.

Full text
Abstract:
Les variations de nombre de copies (VNCs) sont des variations génétiques de grande taille qui ont été détectées parmi les individus de tous les organismes multicellulaires examinés à ce jour. Ces variations ont un impact considérable sur la structure et la fonction des gènes et ont été impliquées dans le contrôle de différents traits phénotypiques. Chez les plantes, les caractéristiques génétiques des VNCs sont encore peu caractérisées et les connaissances concernant les VNCs sont encore plus limitées chez les espèces arborescentes. Les objectifs principaux de cette thèse consistaient i) au développement d’une approche pour la détection de VNCs dans l’espace génique de conifères arborescents appartenant à l’espèce P. glauca, ii) à l’estimation du taux de mutation des VNCs à l’échelle du génome et iii) à l’examen des profils de transmission des VNCs d’une génération à la suivante. Nous avons utilisé des données brutes de génotypage par puces de SNPs qui ont été générées pour 3663 individus appartenant à 55 familles biparentales, et avons examiné plus de 14 000 gènes pour identifier des VNCs. Nos résultats montrent que les VNCs affectent une petite proportion de l’espace génique. Les polymorphismes de nombre de copies observés chez les descendants étaient soit hérités soit générés par des mutations spontanées. Notre analyse montre aussi que les estimés du taux de mutation couvrent au moins trois ordres de grandeur, pouvant atteindre de hauts niveaux et variant pour différents gènes, allèles et classes de VNCs. Le taux de mutation du nombre de copies était aussi corrélé au niveau d’expression des gènes et la relation entre le taux de mutation et l’expression des gènes était mieux expliquée dans le cadre de l’hypothèse de barrière par la dérive génétique. Concernant l’hérédité des VNCs, nos résultats montrent que la plupart de ces derniers (70%) sont transmises en violation des lois mendéliennes de l’hérédité. La majorité des distorsions de transmission favorisaient la transmission d’une copie et contribuaient à la restauration rapide du génotype à deux-copies dans la génération suivante. Les niveaux de distorsion observés variaient considérablement et étaient influencés par des effets parentaux et des effets liés au contexte génétique. Nous avons aussi identifié des situations où la perte d’une copie de gène était favorisée et soumise à différentes formes de pressions sélectives. Cette étude montre que les mutations de novo et les distorsions de transmission de VNCs influencent la diversité génétique présente chez une espèce et jouent un rôle important dans l’adaptation et l’évolution.
Copy number variations (CNVs) are large genetic variations detected among the individuals of every multicellular organism examined so far. These variations have a considerable impact on gene structure and function and have been shown to be involved in the control of several phenotypic traits. In plants, the key genetic features of CNVs are still poorly understood and even less is known about CNVs in trees. The goals of this thesis were to i) develop an approach for the identification of CNVs in the gene space of the conifer tree Picea glauca, ii) estimate the rate of CNV generation genome-wide and iii) examine the transmission patterns of CNVs from one generation to the next. We used SNP-array raw intensity genotyping data for 3663 individuals belonging to 55 full-sib families to scan more than 14 000 genes for CNVs. Our findings show that CNVs affect a small proportion of the gene space and copy number variants detected in the progeny were either inherited or generated through de novo events. Our analyses show that copy number (CN) mutation rate estimates spanned at least three orders of magnitude, could reach high levels and varied for different genes, alleles and CNV classes. CN mutation rate was also correlated with gene expression levels and the relationship between mutation rate and gene expression was best explained within the frame of the drift-barrier hypothesis (DBH). With regard to CNV inheritance, our results show that most CNVs (70%) are transmitted from the parents in violation of Mendelian expectations. The majority of transmission distortions favored the one-copy allele and contributed to the rapid restoration of the two-copy genotype in the next generation. The observed distortion levels varied considerably and were influenced by parental, partner genotype and genetic background effects. We also identified instances where the loss of a gene copy was favored and subject to different types of selection pressures. This study shows that de novo mutations and transmission distortions of CNVs contribute both to the shaping of the standing genetic variation and play an important role in species adaptation and evolution.
APA, Harvard, Vancouver, ISO, and other styles
34

Song, Lei. "Computational Analysis of Genome-Wide DNA Copy Number Changes." Thesis, Virginia Tech, 2011. http://hdl.handle.net/10919/32462.

Full text
Abstract:
DNA copy number change is an important form of structural variation in human genome. Somatic copy number alterations (CNAs) can cause over expression of oncogenes and loss of tumor suppressor genes in tumorigenesis. Recent development of SNP array technology has facilitated studies on copy number changes at a genome-wide scale, with high resolution. Quantitative analysis of somatic CNAs on genes has found broad applications in cancer research. Most tumors exhibit genomic instability at chromosome scale as a result of dynamically accumulated genomic mutations during the course of tumor progression. Such higher level cancer genomic characteristics cannot be effectively captured by the analysis of individual genes. We introduced two definitions of chromosome instability (CIN) index to mathematically and quantitatively characterize genome-wide genomic instability. The proposed CIN indices are derived from detected CNAs using circular binary segmentation and wavelet transform, which calculates a score based on both the amplitude and frequency of the copy number changes. We generated CIN indices on ovarian cancer subtypesâ copy number data and used them as features to train a SVM classifier. The experimental results show promising and high classification accuracy estimated through cross-validations. Additional survival analysis is constructed on the extracted CIN scores from TCGA ovarian cancer dataset and showed considerable correlation between CIN scores and various events and severity in ovarian cancer development. Currently our methods have been integrated into G-DOC. We expect these newly defined CINs to be predictors in tumors subtype diagnosis and to be a useful tool in cancer research.
Master of Science
APA, Harvard, Vancouver, ISO, and other styles
35

Mouka, Aurélie. "Analyse des variations du nombre de copies d'ADN dans une cohorte d'hommes infertiles et génération de modèles génétiques d’étude de la méiose à partir de cellules iPS de patients infertiles." Thesis, Université Paris-Saclay (ComUE), 2017. http://www.theses.fr/2017SACLS300/document.

Full text
Abstract:
L’infertilité représente un problème majeur de santé publique en concernant 10 à 15% des couples en âge de procréer. Un facteur masculin est responsable de l’infertilité du couple dans près de la moitié des cas. Pour environ 30% d'entre eux, l'étiologie reste inexpliquée. Le premier axe du travail a concerné l’étude moléculaire d’une cohorte de patients infertiles (azoospermie non-obstructive/cryptozoospermie ou désordre du développement sexuel ou DSD) pour lesquels les analyses du caryotype standard et/ou des microdélétions des régions AZF par PCR n’ont pas permis d’expliquer le phénotype. L'impact des variations de nombre de copies de l'ADN (CNV) détectées par l'hybridation génomique comparative sur puce à ADN est peu documenté. Un design personnalisé de puce à ADN de format 400K, pangénomique et enrichi sur un large panel de 445 gènes liés à l'infertilité et à un DSD a été développé. Cette puce a permis l’identification de 171 CNV d’intérêt. Ces résultats soulignent l’intérêt de ce design comme outil diagnostic dans le cadre du bilan de l’infertilité masculine. Le second axe du travail a été de modéliser l’infertilité masculine in vitro dans un contexte d’anomalie génétique. Des cellules souches pluripotentes induites humaines (hiPS) ont été générées à partir d’érythroblastes de deux patients infertiles porteurs d’un remaniement chromosomique complexe ou d’un caryotype 46,XX-SRY négatif avec mutation du gène de l’AMH. Dans un deuxième temps, la fonctionnalité des lignées de cellules hiPS générées a été testée par différenciation in vitro en cellules germinales primordiales (CGP). Elles expriment les marqueurs clés du stade CGP dont SOX17, le déterminant germinal le plus précoce des CGP. Les perspectives de ce travail seront de poursuivre la différenciation germinale vers des stades plus matures et ainsi de pouvoir étudier le processus méiotique dans un contexte d’anomalie génétique
Infertility represents a major public health problem and concerns 10 to 15% of couples in the general population. A male factor is responsible for the infertility of the couple in about half of all cases. In approximately 30% of them, the etiology remains unexplained.The first working axis concerned the molecular study of a cohort of infertile patients (nonobstructiveazoospermia/ cryptozoospermia and disorder of the sex development or DSD) for whom analyses of standard karyotype and/or microdeletions of AZF regions were not able to explain the phenotype. The impact of copy number variations of DNA (CNVs) detected by comparative genomic hybridization (CGH-array) is poorly documented. A custom design 400K micoarray, genome-wide and enriched on a wide panel of 445 genes linked with infertility and DSD has been achieved. This array allowed the identification of 171 CNVs of interest.These results underline the potential of this design for diagnosis of male infertility. The second objective of this work was the in vitro modelisation of male infertility in a context of genetic abnormality. For that purpose, human induced pluripotent stem cells (hiPSCs) were generated from erythroblasts by means of not integrative Sendaï virus, in two patients carrying genetic abnormalities (complex chromosomal rearrangement and 46,XX-SRY negative karyotype associated with AMH gene mutation). Secondly, functionality of hiPSCs generated was tested by germ cells in vitro differentiation. Primordial germ cell (PGC) stage was successfully obtained. Cells expressed key PGC markers such as SOX17. The perspectives of this work will be to continuethe germinal differentiation towards more mature stages and so to be able studying the meiotic process in a context of genetic abnormality
APA, Harvard, Vancouver, ISO, and other styles
36

Newman, Jacquelyn. "The effectiveness of low copy number DNA in criminal investigation." Thesis, Teesside University, 2009. http://hdl.handle.net/10149/112655.

Full text
Abstract:
When offenders commit crime there is the potential that they may leave behind trace amounts of their DNA, even when there has been no apparent body fluid spill. During the examination of crime scenes, scene investigators try to identify areas that may be sampled to locate these traces. Specialist techniques are then required within the laboratory to enable such small amounts to be analysed to obtain a profile. These techniques are referred to as Low Template DNA analysis (LTDNA), of which Low Copy Number DNA (LCN DNA) is one instance. In 2008, following the Omagh Bombing trial, and comments made by Judge Weir, the UK Forensic Regulator commissioned a review of the science of LTDNA analysis. The subsequent report made specific mention of the fact that there was no available information on the success rate of the use of such DNA techniques and that there seemed to be confusion over what constituted a success. The report went on to state that there was no information on where such trace amounts of DNA were likely to be found, or what factors could influence the likelihood of obtaining a trace DNA profile (Caddy, 2008). This research considered the outcomes of LCN DNA analysis from 3,552 samples to try to establish where trace amounts of DNA could be found, whether some areas sampled were more successful in generating profiles than others, and the likelihood of the profiles obtained being of use to a criminal investigation. Analysis of results identified areas that were more successful in generating profiles of use to an investigation and highlighted significant differences in results across a variety of items from which samples were taken. DNA samples taken from items associated with communication such as mobile phones were much more likely to produce a profile useful to a criminal investigation than those taken from fixed surfaces within premises. The results obtained showed that obtaining a DNA profile did not necessarily correlate with the profile being of use to a criminal investigation. This was due to the fact that a large number of these profiles were anticipated eliminations from legitimate sources. Items that produced high numbers of profiles but were anticipated eliminations, and therefore of no value to an investigation, came from items associated with skin samples and clothing. The research went further to identify key factors that affected the profiling rates. Factors that had a positive influence on the ability to obtain a profile included: any area that had been in close proximity to saliva (direct contact was not required); samples that had been recovered from the inside of premises or vehicles and therefore protected from the elements; those that were dry; items that were of a porous nature; and those that had a rough texture. No differences were found between the actual surface materials (plastic, glass, wood, metal), as all showed a propensity to generate profiles. Other factors that were considered but proved to have no effect on the profiling rates included seasonal differences and whether the area targeted for sampling was clearly defined. Items that had had high contact with a victim, were recovered from outside or had been wet, all proved to be less useful to an nvestigation. A further finding of the research was that swabs that had been recovered and stored frozen appeared to deteriorate in their ability to profile. This was particularly notable if they were submitted later than 5 months after recovery. Items stored in dry conditions did not deteriorate in this way. Overall the research can be used to provide investigators with the knowledge of what areas of crime scenes are most likely to yield trace DNA material, the key factors that can affect the likelihood of obtaining a profile, and those areas that are more likely to produce profiles useful to criminal investigations.
APA, Harvard, Vancouver, ISO, and other styles
37

Smith, Pamela. "SIMPLIFIED LOW COPY NUMBER DNA ANALYSIS BY POST PCR PURIFICATION." Master's thesis, University of Central Florida, 2006. http://digital.library.ucf.edu/cdm/ref/collection/ETD/id/3474.

Full text
Abstract:
Frequently evidentiary items contain an insufficient quantity of DNA to obtain complete or even partial DNA profiles using standard forensic gentotyping techniques. Here, various methods of post PCR purification were evaluated for their effects on the sensitivity of fluophore-based allelic detection. A method of post PCR purification is described which increases the sensitivity of standard 28 cycle PCR such that low copy number DNA templates (<100 pg DNA) can be analyzed. Full profiles were consistently obtained with as little as 20 pg template DNA without increased cycle number. In mock case type samples with dermal ridge fingerprints, genetic profiles were obtained by amplification with 28 cycles followed by post-PCR purification whereas no profiles were obtained without purification of the PCR product. Allele drop-out, increased stutter, and contamination (allele drop-in) typical of LCN analysis were observed. A single incident of contamination was observed in a reagent blank (not duplicated upon re-amplification) however, no contamination was observed in negative amplification controls.
M.S.
Department of Chemistry
Arts and Sciences
Industrial Chemistry
APA, Harvard, Vancouver, ISO, and other styles
38

Filho, Gil Monteiro Novo. "Estudo das variações no número de cópias (CNVs) das regiões subteloméricas em portadores de malformações congênitas e deficiência intelectual." Universidade de São Paulo, 2014. http://www.teses.usp.br/teses/disponiveis/5/5141/tde-13012015-115515/.

Full text
Abstract:
A variação no número de cópias gênicas (CNVs) é a alteração estrutural mais prevalente no genoma humano. Estas alterações estão presentes em alta proporção nos subtelômeros, quando comparados com o resto do genoma. Isso ocorre principalmente porque essas regiões são ricas em genes e porque apresentam sequências repetitivas que as tornam suscetíveis a rearranjos genômicos. Na literatura os rearranjos subteloméricos, como deleções, duplicações e translocações estão associados à etiologia da deficiência intelectual (DI), do atraso no desenvolvimento neuropsicomotor (ADNPM) e das malformações congênitas (MC). Estudos prévios com pacientes com DI revelaram taxas de CNVs patogênicas em regiões subteloméricas variando de 2,4% a 4,8%. Os objetivos desse trabalho foram: investigar a presença das CNVs subteloméricas nos pacientes portadores de malformações congênitas e deficiência intelectual, caracteriza-las quanto a extensão e patogenicidade e sugerir os mecanismos produtores dessas alterações. Foram analisadas 105 amostras de DNA de pacientes com DI/ADNPM associada a MC. Utilizamos a técnica de MLPA (Multiplex Ligation-dependent Probe Amplification) com kits específicos para regiões subteloméricas (P036 e P070). Dentre os pacientes que apresentaram alterações pela técnica de MLPA, 7 pacientes foram submetidos à técnica de array, utilizando as plataformas Agilent SurePrint G3 Genoma Humano microarray 180 K e HumanCytoSNP-12 BeadChip Illumina®. O MLPA permitiu identificar alterações subteloméricas em 14,28% dos casos, sendo 7 pacientes com uma deleção isolada, 7 pacientes apresentaram uma deleção concomitante a uma duplicação e um paciente apresentou duas duplicações. A análise por array confirmou as alterações encontradas por MLPA e permitiu a delimitação acurada dos pontos de quebra genômicos. A análise combinada utilizando bioinformática com diferentes ferramentas: DGV (Database of Genomic Variants), DECIPHER (Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources), UCSC Genome Bioinformatics e DAVID (Database for Annotation, Visualization and Integrated Discovery), revelou um total de 8 genes sugestivos de serem responsáveis por fenótipos clínicos distintos. Dentre eles, o gene DIAPH1 foi relacionado à microcefalia, o gene CTNND2 à DI e o gene OTOS à surdez. O array revelou elementos repetitivos, sequências teloméricas e/ou STRs nas regiões próximas aos pontos de quebra estudados. Também nos permitiu inferir que os pontos de quebra com deleção simples são sugestivos de NHEJ ou MMEJ e os casos que apresentaram rearranjos complexos: FoSTeS ou MMBIR. A estratégia teve sucesso em identificar CNVs subteloméricas e associá-las ao fenótipo dos pacientes e, adicionalmente, possibilitou a sugestão dos mecanismos que as produziram
Copy number variation (CNV) is the most prevalent structural changes in the human genome. These changes are present in a high rate in subtelomere compared with the rest of the genome. This is primarily because these regions are gene rich and because of the presence of repetitive sequences that make them susceptible to genomic rearrangements. Subtelomeric rearrangements, such as deletions, duplications and translocations are associated with the etiology of intellectual disability (ID), the developmental delay (DD) and congenital malformations (CM). Previous studies with patients with ID have revealed rates of pathogenic CNVs in subtelomeric regions ranging from 2.4% to 4.8%. The objectives of this study were to investigate the presence of subtelomeric CNVs in patients with congenital malformations and intellectual disability, characterized them as the extent and pathogenicity and suggest mechanisms of formation. DNA samples from 105 patients with ID/DD associated with CM were analysed. We use the MLPA (Multiplex Ligationdependent Probe Amplification) technique with specific subtelomeric regions (P036 and P070) kits. Among patients with CNVs changes by MLPA, seven were submitted to array technique, using Agilent SurePrint G3 Human Genome microarray HumanCytoSNP or 180 K-12 BeadChip Illumina® platforms. The subtelomeric MLPA analysis identified alterations in 14.28% of cases, 7 patients presented an isolated deletion, 7 patients presented a concomitant deletion and duplication and 1 patient presented two duplications. The array analysis confirmed the alterations found by MLPA and allowed the accurate delineation of the genomic break points. The analysis combined with bioinformatics using different tools: DGV (Database of Genomic Variants), Decipher (Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources), UCSC Genome Bioinformatics and DAVID (Database for Annotation, Visualization and Integrated Discovery), revealed a total of eight genes that are suggestible responsible for distinct clinical phenotypes. Among them, DIAPH1 gene was related to microcephaly, CTNND2 gene to ID and OTOS gene to deafness. Array revealed repetitive elements, telomeric sequences and / or STR close to breakpoints regions. We propose that the breakpoints with single deletions are suggestive of NHEJ or MMEJ and cases with complex rearrangements: FoSTeS or MMBIR. This strategy could identify subtelomeric CNVs, improve the genotype-phenotype association and also allowed the investigation of mechanisms for formation
APA, Harvard, Vancouver, ISO, and other styles
39

Li, Zhiwei. "Characterising copy number polymorphisms using next generation sequencing data." Thesis, Uppsala universitet, Institutionen för biologisk grundutbildning, 2019. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-386050.

Full text
Abstract:
We developed a pipeline to identify the copy number polymorphisms (CNPs) in the Northern Swedish population using whole genome sequencing (WGS) data. Two different methodologies were applied to discover CNPs in more than 1,000 individuals. We also studied the association between the identified CNPs with the expression level of 438 plasma proteins collected in the same population. The identified CNPs were summarized and filtered as a population copy number matrix for 1,021 individuals in 243,987 non-overlapping CNP loci. For the 872 individuals with both WGS and plasma protein biomarkers data, we conducted linear regression analyses with age and sex as covariance. From the analyses, we detected 382 CNP loci, clustered in 30 collapsed copy number variable regions (CNVRs) that were significantly associated with the levels of 17 plasma protein biomarkers (p < 4.68×10-10).
APA, Harvard, Vancouver, ISO, and other styles
40

Lourenço, Gustavo Jacob 1978. "Identificação de genes de susceptibilidade herdada para o carcinoma de células escamosas de base de língua por genotipagem em larga escala." [s.n.], 2011. http://repositorio.unicamp.br/jspui/handle/REPOSIP/308619.

Full text
Abstract:
Orientadores: Carmen Silvia Passos Lima, Fernando Ferreira Costa
Tese (doutorado) - Universidade Estadual de Campinas, Faculdade de Ciências Médicas
Made available in DSpace on 2018-08-19T13:59:25Z (GMT). No. of bitstreams: 1 Lourenco_GustavoJacob_D.pdf: 4599367 bytes, checksum: 0a02bc7c2e5acd6b81b6cbb948444b69 (MD5) Previous issue date: 2011
Resumo: Alterações genéticas herdadas, como os polimorfismos gênicos de base única (SNPs) e as variações no número de cópias do DNA (CNVs), foram associadas com o risco de carcinoma de células escamosas (CEC) de base de língua (BL) em poucos estudos. O CEC de BL é um tumor que determina altas taxas de morbidade e mortalidade, no entanto, sua associação com polimorfismos genéticos não está estabelecida. Frente ao exposto, o objetivo deste estudo foi o de avaliar os papéis de SNPs e CNVs no CEC de BL. O DNA genômico foi obtido de amostras de sangue periférico de 49 pacientes com CEC de BL e de 49 controles. Cada amostra foi analisada por meio de lâminas com microarranjos de DNA contendo 500.568 SNPs e 420.000 CNVs (Affymetrix®). A digestão enzimática do DNA, a ligação de adaptadores, a amplificação, a fragmentação, a marcação, a hibridização, as lavagens e a leitura das intensidades dos sinais das sondas foram realizadas de acordo com instruções do fabricante. Os dados obtidos foram analisados utilizando o programa Bioconductor e o algoritmo crlmm. Para os SNPs, as diferenças entre os grupos foram analisadas por meio da regressão logística múltipla. Para as CNVs, os dados obtidos foram analisados por meio do programa Partek®. Regiões de ganhos ou perdas significativas de DNA foram determinadas pelo algoritmo cbs. Os genes de interesse foram escolhidos por meio do programa DAVID. Nós observamos que a frequência de 6.609 SNPs foi distinta entre pacientes com CEC de BL e controles (P< 0,01). Cinquenta e dois SNPs (0,8%) estiveram localizados nas regiões codificantes do DNA, 51 (0,8%) estiveram nas regiões 3' e 5' não traduzidas, 3.461 estiveram em regiões regulatórias de transcrição e 3.045 em íntrons. Os SNPs considerados de interesse estiveram localizados nos genes relacionados ao ciclo celular (ERP29, MCC e PTCH1), à transcrição (IKBKAP e ZNF415) e à adesão celular (COL22A1, LEF1 e LY6K). Nós identificamos regiões do DNA que apresentaram duplicações em genes relacionados com a proliferação celular (ADAM3A, ADAM5P e DDT), apoptose (FAM90A), mecanismo de defesa (DEFB) e metabolismo de carcinógenos (GSTs). Nós também observamos genes deletados relacionados à apoptose (BLC2) e aos receptores do olfato (ORs). Nossos resultados sugerem que SNPs e CNVs em genes relacionados com a origem e a progressão de tumores podem predispor indivíduos ao CEC de BL. No entanto, esses resultados devem ser validados por genotipagens de número maior de indivíduos e por análises funcionais de proteínas codificadas por alelos distintos de genes polimórficos
Abstract: Inherited genetic alterations, such as single nucleotide polymorphisms (SNPs) and copy number variations (CNVs), were described in association with base of tongue (BT) squamous cell carcinoma (SCC) risk in only few reports. BTSCC are tumours with high morbidity and mortality rates; however, the association of SNPs and CNVs and BTSCC risk is still not clarified and, therefore, this was the aim of the present study. DNA was extracted of the peripheral blood samples of 49 BTSCC patients and 49 controls. Each sample was genotyped using DNA high-resolution microarrays containing 500.568 SNPs and 420.000 CNVs (Affymetrix®). Further sample processing, including digestion, adaptor ligation, amplification, fragmentation, labelling, hybridization, washing and scanning was assayed according to the standard protocol. Genotype data were acquired by genotyping calling of samples using the crlmm algorithm provided by Bioconductor software, as per the recommended guidelines. For SNPs, the differences between groups were analysed by the logistic regression model. For CNVs, the patients' and controls' data files were imported into the Partek® Genomic Suite. Common aberration analysis was performed on all samples to identify genomic intervals that had statistically significant aberrations. Significantly different regions were determined using the segmentation algorithm. For SNPs, we observed 6.609 SNPs with distinct frequencies between BTSCC patients and controls (P< 0.01). Fifty two SNPs (0.8%) were located in coding sequence of amino acids, 51 (0.8%) in 3' and 5' untranslated regions, 3.461 (52.4%) in up or downstream regions and 3.045 (46.0%) in introns. The SNPs were clustered to their main function, evidencing those localized in genes related to cell cycle and apoptosis (ERP29, MCC and PTCH1), transcriptional process (IKBKAP and ZNF415) and cell adhesion and metastasis (COL22A1, LEF1 and LY6K). We also identified a consistent number of altered regions including duplicated genes, such as involved in cell proliferation and angiogenesis (ADAM3A, ADAM5P and DDT), apoptosis (FAM90A), defensins proteins (DEFB) and metabolism of carcinogens (GSTs); and deleted genes, such as in olfactory receptors (ORs) and apoptosis (BCL2). Our preliminary results suggest that SNPs and CNVs in genes involved in tumour origin and progression may predispose individuals to BTSCC. However, these results should be confirmed by functional studies of coded proteins and validated by genotyping in larger epidemiological studies
Doutorado
Biologia Estrutural, Celular, Molecular e do Desenvolvimento
Doutor em Fisiopatologia Medica
APA, Harvard, Vancouver, ISO, and other styles
41

Costa, Claudia Ismania Samogy. "Copy number variations (CNVs) in Brazilian patients with autism spectrum disorder (ASD)." Universidade de São Paulo, 2018. http://www.teses.usp.br/teses/disponiveis/41/41131/tde-20092018-124809/.

Full text
Abstract:
Autism Spectrum Disorder (ASD) is a heterogeneous group of neurodevelopmental disorders that affects about 1% of the worldwide population and has a strong genetic component. Stereotyped behavior and restricted interests, as well as problems of social interaction and communication characterize ASD. Moreover, in 10% of cases, ASD occurs as a secondary condition in addition to a syndrome, such as Phelan-McDermid syndrome (PMS), which is associated with a great clinical variability. Among genetic factors, copy number variations (CNVs) are one of the most important. However, the clinical significance of many CNVs remains nuclear and there is an underrepresentation of small CNVs associated with ASD in the literature. In this context, this project aimed to 1) characterize large and small CNVs in Brazilian patients with ASD using an array-CGH previously customized in our laboratory. 2) Clinically and genetically describe a cohort of Brazilian patients with PMS, as well as to determine the frequency of this syndrome among Brazilian patients with ASD and other neurodevelopmental disorders. In result, we 1) further validated the customized array-CGH, 2) provided additional evidence of association with ASD for 27 candidate genes, 3) described 15 CNVs never reported in the literature in association with this disorder, 4) presented evidence that around 70% of CNVs found in our cohort are not polymorphism of our population and 5) reinforced the idea of shared molecular pathways among different neurodevelopmental disorders. In addition, we described for the first time a Brazilian cohort of patients with PMS and contributed to the molecular and clinical characterization of this syndrome. We also provided additional evidence of genotype-phenotype association with regard to the presence of renal problems and speech status in patients with PMS and estimated the frequency of this syndrome among Brazilian patients with ASD and intellectual disability (syndromic or not). With these results, we hope to contribute to better understand the ASD and PMS etiology, especially in our population
O Transtorno do Espectro Autista (TEA) corresponde ao um grupo heterogêneo de alterações no neurodesenvolvimento que afeta cerca de 1% da população mundial e apresenta um forte componente genético. O TEA é caracterizado pela presença de comportamento estereotipado e interesses restritos, além de problemas de interação social e comunicação. Além disso, em 10% dos casos, o TEA ocorre como uma condição secundária somada a uma síndrome. Um exemplo é a síndrome de Phelan-McDermid (PMS), associada a uma grande variabilidade clínica. Dentre os fatores genéticos, as variações no número de cópias (CNVs) são um dos mais importantes. No entanto, o significado clínico de muitas CNVs permanece incerto, além de haver juma sub-representação de CNVs pequenas associadas ao TEA na literatura. Dentro deste contexto, este projeto teve como objetivos 1) caracterizar CNVs grandes e pequenas em pacientes brasileiros com TEA utilizando uma lâmina de array-CGH previamente customizada no Laboratório de Genética do Desenvolvimento - USP. 2) descrever clínica e geneticamente uma casuística de pacientes brasileiros com PMS, bem como determinar a frequência desta síndrome em pacientes com TEA e com outras alterações de neurodesenvolvimento. Como resultados, nós 1) validamos a lâmina customizada, 2) fornecemos evidencia adicional de associação com o TEA para 27 genes, 3) descrevemos 15 CNVs nunca reportadas em associação com o transtorno 4) apresentamos evidências de que cerca de 70% das CNVs encontradas em nossa coorte não são polimorfismo de nossa população e 5) reforçamos a ideia de vias moleculares compartilhadas entre diferentes alterações do neurodesenvolvimento. Além disso, descrevemos pela primeira vez uma casuística brasileira de pacientes com PMS e contribuímos para a síndrome. Fornecemos evidência adicional de associação genótipo-fenótipo no que diz respeito à presença de problemas renais e status de fala em pacientes com PMS e estimamos a frequência da síndrome entre pacientes brasileiros com TEA e com deficiência intelectual (sindrômica ou não). Com estes resultados, esperamos ter contribuído para o entendimento da etiologia tanto do TEA, quanto da PMS, sobretudo na nossa população
APA, Harvard, Vancouver, ISO, and other styles
42

Theriault, Mylene A. "Development and Validation of Quantitative PCR Assays for DNA-Based Newborn Screening of 22q11.2 Deletion Syndrome, Spinal Muscular Atrophy, Severe Combined Immunodeficiency and Congenital Cytomegalovirus Infection." Thesis, Université d'Ottawa / University of Ottawa, 2013. http://hdl.handle.net/10393/30318.

Full text
Abstract:
The development of new high throughput technologies able to multiplex disease biomarkers as well as advances in medical treatments has lead to the recent expansion of the newborn screening panel to include DNA-based targets. Four rare disorders; deletion 22q11.2 syndrome and Spinal Muscular Atrophy (SMA), Severe Combined Immunodeficiency (SCID) and Congenital Cytomegalovirus (CMV), are potential candidates for inclusion to the newborn screening panel within the next few years. The major focus of this study was to determine whether 5’-hydrolysis assays developed for the four distinct disorders with specific detection needs and analytical ranges could be combined on the OpenArray system and in multiplexed qPCR reactions. SNP detection of homozygous SMN1 deletions in SMA, CNV detection in the 22q11.2 critical region, and quantification of the SCID biomarker, T-cell receptor excision circles (TRECs) and CMV were all required for disease confirmation. SMA and 22q11.2 gene deletions were accurately detected using the OpenArray system, a first for the technology. The medium density deletion 22q11.2 multiplex successfully identified deletion carriers having either the larger 3 Mb deletion or the smaller 1.5 Mb deletions. Both TREC and CMV targets were detected but with a decrease in sensitivity when compared to their singleplex counterparts. Lastly, copy number detection of the TBX1 was performed when multiplexed with the TREC assay, without a decrease in detection limit of either assay. Here, we provide proof of principal that qPCR multiplexing technologies are amenable to implementation with a newborn screening laboratory.
APA, Harvard, Vancouver, ISO, and other styles
43

Pierre-Jean, Morgane. "Development of statistical methods for DNA copy number analysis in cancerology." Thesis, Université Paris-Saclay (ComUE), 2016. http://www.theses.fr/2016SACLE056/document.

Full text
Abstract:
Les données génomiques issues d'expériences de puces à ADN ou de séquençage ont deux caractéristiques principales: leur grande dimension (le nombre de marqueurs dépassant de plusieurs ordres de grandeurs le nombre d'observations), et leur forte structuration (notamment via les dépendances entre marqueurs). La prise en compte de cette structuration est un enjeu clé pour le développement de méthodes performantes en grande dimension.Cette thèse est axée sur les données présentant une forte structure le long du génome. C'est le cas des données de nombres de copies d'ADN, mais aussi des données de génotypes. La thèse couvre à la fois le développement de méthodes statistiques, l'implémentation logicielle, et l'application des méthodes développées à des jeux de données réelles. Nous avons, en particulier, étudié des méthodes de segmentation, et de dictionary learning. Toutes les implémentations logiciel de ces méthodes sont librement disponibles sous forme de packages R
Genomic data from DNA microarray or sequencing technologies have two major characteristics: their high dimension (number of markers larger than the number of observations), and their strong structuration (dependence between markers). Taking into account this structuration, it is a challenging issue for the development of efficient methods.This work is focused on the data with a strong spatial structuration, namely DNA copy number data in tumor samples. We developed statistical models, software implementations and we applied these developments to real data. We explored in particular segmentation models and dictionary learning methods. All the software Implementations of these methods are freely available as R packages
APA, Harvard, Vancouver, ISO, and other styles
44

Saadati, Hamidreza [Verfasser]. "Systematic analysis of genomic copy number variations in inflammatory bowel diseases / Hamidreza Saadati." Kiel : Universitätsbibliothek Kiel, 2017. http://d-nb.info/1128149230/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
45

Schneider, Silvana. "Estimação de proporções alélicas e genotípicas individuais de dados CNVs (Copy Number Variations)." Universidade Federal de Minas Gerais, 2013. http://hdl.handle.net/1843/BUOS-97YF66.

Full text
Abstract:
Copy Number Variation (CNV) are DNA segments that exhibit variations in the number of copies of a sequence (gene), in relation to the usual number of two copies per individual, ranging from one kilobase to three megabases in size. Numerous studies have identified an association of the variations in the number of copies of some genes with various complex genetic diseases such as lupus, rheumatoid arthritis and type 1 diabetes, HIV infection and malaria. Most methods available for identifying CNVs are able to describe only the total number of copies of a gene or DNA segment per individual, leaving behind the number of copies per chromosome. Gaunt et al. (2010) developed a program called CoNVEM, which is based on the EM algorithm (Expectation-Maximization) to determine the allele frequencies in haploids of CNV data, assuming the data are in Hardy-Weinberg equilibrium (HWE). However, when the data are in Hardy-Weinberg Disequilibrium there aren´t any statistical tools to estimate the proportions of allelic and genotypic data CNVs. We propose a method to estimate these proportions when there is inbreeding in the population (imbalance), based on the EM algorithm and the approach of the profiled likelihood function. The calculations have been implemented in a program that we call by CNVice (Inbreeding Coefficients Estimation for CNV data), using R programming language, developed in partnership with the Laboratory of Human Genome Diversity, http://ldgh.com.br/, of Federal University of Minas Gerais.
Copy Number Variation (CNVs) são segmentos de DNA que apresentam variações do número de cópias de uma sequência (gene), em relação ao número usual de duas cópias por indivíduo, podendo variar de um kilobase a três megabases de tamanho. E, inúmeras pesquisas já identificaram a associação de variações no número de cópias de alguns genes com diversas doenças genéticas complexas, tais como o lúpus, artrite reumatoide e diabetes do tipo 1, infecções por HIV e malária. A maioria dos métodos disponíveis para a identificação de CNVs são capazes de descrever apenas o número total de cópias de um gene ou segmento de DNA por indivíduo, deixando subjacente o número de cópias por cromossomo. Gaunt et al. (2010) desenvolveram um programa chamado CoNVEM, baseado no Algoritmo EM (Expectation-Maximization) para determinar a proporção alélica em dados haploides de CNV, supondo que os dados estão em Equilíbrio de Hardy-Weinberg (EHW). No entanto, quando os dados estão em Desequilíbrio de Hardy-Weinberg não há ferramentas estatísticas para estimarmos as proporções alélicas e genotípicas de dados de CNVs. Propomos um método capaz de estimar essas proporções quando existe endogamia na população (desequilíbrio), baseado no Algoritmo EM e na abordagem da função de verossimilhança perfilada. Os cálculos foram implementados em um programa que denominamos por CNVice (Inbreeding Coefficients Estimation for CNV data), utilizando linguagem de programação R, realizado em parceria com o Laboratório de Diversidade Genética Humana, http://ldgh.com.br/, da Universidade Federal de Minas Gerais.
APA, Harvard, Vancouver, ISO, and other styles
46

Zhang, Yue. "Detection copy number variants profile by multiple constrained optimization." HKBU Institutional Repository, 2017. https://repository.hkbu.edu.hk/etd_oa/439.

Full text
Abstract:
Copy number variation, causing by the genome rearrangement, generally refers to the copy numbers increased or decreased of large genome segments whose lengths are more than 1kb. Such copy number variations mainly appeared as the sub-microscopic level of deletion and duplication. Copy number variation is an important component of genome structural variation, and is one of pathogenic factors of human diseases. Next generation sequencing technology is a popular CNV detection method and it has been widely used in various fields of life science research. It possesses the advantages of high throughput and low cost. By tailoring NGS technology, it is plausible to sequence individual cells. Such single cell sequencing can reveal the gene expression status and genomic variation profile of a single-cell. Single cell sequencing is promising in the study of tumor, developmental biology, neuroscience and other fields. However, there are two challenging problems encountered in CNV detection for NGS data. The first one is that since single-cell sequencing requires a special genome amplification step to accumulate enough samples, a large number of bias is introduced, making the calling of copy number variants rather challenging. The performances of many popular copy number calling methods, designed for bulk sequencings, are not consistent and cannot be applied on single-cell sequenced data directly. The second one is to simultaneously analyze genome data for multiple samples, thus achieving assembling and subgrouping similar cells accurately and efficiently. The high level of noises in single-cell-sequencing data negatively affects the reliability of sequence reads and leads to inaccurate patterns of variations. To handle the problem of reliably finding CNVs in NGS data, in this thesis, we firstly establish a workflow for analyzing NGS and single-cell sequencing data. The CNVs identification is formulated as a quadratic optimization problem with both constraints of sparsity and smoothness. Tailored from alternating direction minimization (ADM) framework, an efficient numerical solution is designed accordingly. The proposed model was tested extensively to demonstrate its superior performances. It is shown that the proposed approach can successfully reconstruct CNVs especially somatic copy number alteration patterns from raw data. By comparing with existing counterparts, it achieved superior or comparable performances in detection of the CNVs. To tackle this issue of recovering the hidden blocks within multiple single-cell DNA-sequencing samples, we present an permutation based model to rearrange the samples such that similar ones are positioned adjacently. The permutation is guided by the total variational (TV) norm of the recovered copy number profiles, and is continued until the TV-norm is minimized when similar samples are stacked together to reveal block patterns. Accordingly, an efficient numerical scheme for finding this permutation is designed, tailored from the alternating direction method of multipliers. Application of this method to both simulated and real data demonstrates its ability to recover the hidden structures of single-cell DNA sequences.
APA, Harvard, Vancouver, ISO, and other styles
47

Lagoa, Arlindo Marques. "Análise genética de impressões digitais - Amostras Low Copy Number." Dissertação, Faculdade de Medicina da Universidade do Porto, 2007. http://hdl.handle.net/10216/22055.

Full text
Abstract:
Mestrado em Ciências Forenses
Master Degree Course in Forensic Sciences
A possibilidade de analisar amostras com quantidades exíguas de material genético (amostras Low Copy Number ou LCN), em que estão presentes apenas algumas células, tem alterado a forma de encarar a cena do crime. Alguns vestígios que até agora não eram considerados como susceptíveis de proporcionarem resultados, podem actualmente ser analisados com sucesso. As impressões digitais são um bom exemplo. Estes vestígios apresentam um baixo número de células, permitindo apenas recuperar quantidades de DNA inferiores a 100 pg. Assim, para a análise do DNA nuclear, é necessário implementar sistemas muito sensíveis que consistem, habitualmente, no aumento do número de ciclos da PCR. Contudo, alguns artefactos são produzidos, tornando difícil a interpretação dos electroforectogramas. Neste trabalho pretendeu-se comparar a aplicação do estudo de STR autossómicos, Y-STR e miniSTR na análise genética de impressões digitais, partindo do conceito do aumento do número de ciclos como estratégia para se obter maior sensibilidade. Procedeu-se também à amplificação total do genoma e nested-PCR, como métodos alternativos ao aumento do número de ciclos. Adicionalemente, neste estudo tentou-se perceber a influência dos principais métodos reveladores de impressões digitais (cianoacrilato, pó magnético e pó branco) na análise do DNA. Os resultados mostram que o aumento do número de ciclos é a melhor opção como método para aumentar a sensibilidade. Constata-se também que o DNA extraído de impressões digitais encontra-se parcialmente degradado, obtendo-se diferenças significativas entre loci com fragmentos de amplificação menores e maiores do que 200 pb. Dos diferentes marcadores caracterizados verifica-se que, em termos de percentagem de alelos detectados, os miniSTR proporcionam os melhores resultados. Por outro lado, os Y-STR parecem altamente sensíveis à degradação ou presença de inibidores, pelo que são menos robustos para este tipo de análises. Verifica-se também que os perfis LCN são drasticamente afectados por artefactos, principalmente os derivados de variação estocástica, como o allele dropout e o desequilíbrio heterozigótico. A determinação de perfis de consenso permite reduzir alguns destes artefactos. Dos métodos de revelação estudados, o cianoacrilato é o que apresenta menor influência na análise e, pelo contrário, o pó branco provoca os resultados mais negativos.
The possibility to perform low copy number DNA typing, when just a few cells are available, as changed the way how crime scene investigations is faced. Nowadays it is possible to successfully type some evidence that couldn t be considered until now. Fingerprints are a good example of those. Since that just a few cells are present in this evidence (enabling recovery of low quantities of DNA, fewer than 100pg) just very sensitive systems can detect nuclear DNA. The most used method is definitely increasing the number of PCR cycles. However, increased occurrence of stutters and artifacts that reduced the quality of the DNA profile is normally observed. The present work aimed to compare the application of autosomic STR, Y-STR and miniSTR markers, based on the concept of increased number of PCR cycles as a strategy to achieve more sensitivity. Some other methods, such as whole genome amplification and nested-PCR, were also evaluated as an alternative way to reach the desired sensitivity. Another goal was to determine the influence of several reagents for developing latent fingerprints (cyanoacrylate fuming, magnetic powder and white powder) in DNA typing. The results shows that increasing the number of PCR cycles still is the best way to attain the required sensitivity. Moreover we could realize that DNA was partially degraded, once there were observed significant differences between loci larger and smaller than 200bp. Among all markers miniSTR showed to perform the best results in terms of detected alleles percentage. On the other hand, Y-STR seemed to be highly affected in the presence of degraded DNA and PCR inhibitors, which makes them less robust for these analyses. LCN profiles are significantly affected by artifacts, like allele dropout and heterozygous imbalance, derived from stochastic fluctuation. Reporting consensus profiles reduces artifact inherent errors. Finally, cyanoacrylate proved to have a minimum negative effect on DNA profiling, while white powder was the worst reagent.
APA, Harvard, Vancouver, ISO, and other styles
48

Enyakoit, G. O. "Cytogenetic analysis of DNA copy number aberrations in high malignancy grade astrocytomas." Thesis, University College London (University of London), 2008. http://discovery.ucl.ac.uk/1444158/.

Full text
Abstract:
Astrocytomas are the most common variety of primary tumours of the central nervous system (CNS). The incidence increases with age, peaking in patients aged 65--75 years. They are generally unresponsive to treatment, and most patients die within one year of diagnosis. Recent genetic studies of astrocytoma susceptibility syndromes, familial- and sporadic astrocytomas have led to the discovery of many genes and molecular mechanisms underlying astrocytoma oncogenesis. A few of the genes involved in inherited astrocytoma associated-syndromes (e.g., Cowden and Li-Fraumeni syndromes) are also strongly implicated in sporadic astrocytomas. However for several other well characterised genes i.e. those mutated in Tuberous sclerosis (TSC) and Neurofibromatosis (NF) any evidence for involvement in sporadic astrocytomas is much less clear. The objective of this study was to undertake a genome-wide survey of high malignancy grade astrocytomas with a view to ascertaining the distribution and prevalence of copy number aberrations, search for associations with prognosis and outcomes to treatment, and to discover possible novel pathways of oncogenesis. Thirty-two high malignancy grade astrocytomas were investigated. Twenty were available as frozen biopsies and 12 as short-term cell cultures. Genomic profiling of all 32, comprising 6 tumours of WHO Grade III and 26 of Grade IV, was achieved by the method of Comparative Genomic Hybridisation onto metaphase chromosomes. 7 of the tumours were investigated by array CGH, with one further investigated by MFISH. Two tumours did not reveal aberrations. For the other 30 tumours, data pooled from a minimum of 10 profiles of each tumour were analysed. Recurrent DNA copy number gains and losses were detected across the genome. In a number of tumours aberrations spanned loci of established candidate genes previously associated with sporadic astrocytomas, on chromosomes 7, 9p, lOq, 12q, 13q and 17p. In addition over 70% of 'sporadic' tumours appeared to have DNA-copy number aberrations implicating genes with established roles in astrocytoma-susceptibility syndromes. The chromosomal region 9q34 (site of TSC1) appeared to be under-represented in 25% of the tumours, while 16pl3 (site of TSC2) was diminished in -38%. Similarly, loci for NF1 and NF2 were involved in aberrations in -10% and 38% of the cases respectively, as were those of PMS2 (22%), APC (19%) and a number of miss- I Cytogenetic Analysis of DNA Copy Number Aberrations in High Malignancy Grade Astrocytomas match repair (MMR) genes. Eight tumours had probable loss at lp36. Several novel locations were also suggested An attempt to correlate DNA copy number alterations with survival showed that among patients with grade IV tumours, there were on average far fewer chromosome aberrations per tumour in four of the five patients surviving longer than one year after diagnosis than in those who died before this. There was some suggestion of a worse prognosis in Grade IV tumours with a specific deletion of lp36, which would agree with a previous report. The only Grade IV tumour that was studied by all three approaches showed good agreement between array and metaphase CGH. In addition, array CGH revealed small regions of loss in the region of PTEN (CHR lOq) and TP53 (CHR 17p) below the resolution of the metaphase CGH. The M-FISH revealed very large numbers of chromosomes and several translocations, and comparison of the microarray data and the MFISH data suggests possible candidate regions for breakpoints. The data are discussed in the light of previous work and with a view to the possibility that there may be some diversity in the cellular origin of astrocytomas and that haploinsufficiency may play some role in oncogenesis.
APA, Harvard, Vancouver, ISO, and other styles
49

Dillingham, Mark Simon. "Biochemical studies on DNA helicases." Thesis, University of Oxford, 1999. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.312245.

Full text
APA, Harvard, Vancouver, ISO, and other styles
50

Rantanen, Anja. "Regulation of mitochondrial transcription and mtDNA copy number in mammals /." Stockholm, 2003. http://diss.kib.ki.se/2003/91-7349-526-3/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography